Introduction
============

Diabetes mellitus is a major risk factor for cardiovascular disease (CVD), and is associated with dyslipidemia characterized by increased serum levels of triglycerides (TG), remnant lipoprotein cholesterol (RLP-C), and small dense low-density lipoproteins (sdLDL), and decreased levels of high-density lipoprotein cholesterol (HDL-C)^[@bib1]--[@bib14])^. Subjects with prediabetes are also at increased CVD risk, and often have dyslipidemia^[@bib5])^. Significant CVD risk factors in patients with diabetes include hypertension, smoking, increased levels of serum glucose and LDL-C, and decreased levels of HDL-C^[@bib6])^. Lowering LDL-C levels with statin therapy has been associated with significant reductions in CVD events in patients with diabetes^[@bib7]--[@bib11])^.

In the United States, it has been recommended that all patients with established CVD and diabetes over the age of 40 years with LDL-C levels \> 70 mg/dL, an LDL-C value ≥ 190 mg/dL, or a ten-year CVD risk ≥ 7.5% be placed on statin therapy in addition to lifestyle modification in order to achieve a significant LDL-C reduction^[@bib12]--[@bib14])^. More recently, it has been suggested that in addition to statins, the use of ezetimibe, and/or proprotein convertase subtilisin kexin 9 inhibitors can be considered to reduce LDL-C levels to \< 70 mg/dL in CVD patients and \< 100 mg/dL in high-risk patients including patients with diabetes^[@bib15],\ [@bib16])^. In the United States, there are no recommendations with regard to TG targets^[@bib12]--[@bib16])^. In Taiwan, current recommendations with regard to LDL-C targets of therapy are the same as in the United States, but it was also recommended that TG levels be lowered to \< 150 mg/dL^[@bib17],\ [@bib18])^. In Japan, it was recommended that CVD patients have their LDL-C values lowered to \< 100 mg/dL, and \< 120 mg/dL for diabetics, and for both groups to get TG levels lowered to \< 150 mg/dL^[@bib19])^. In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, it was documented that diabetic subjects on statin therapy did not get additional benefit from the addition of fenofibrate therapy, unless their TG levels were \> 204 mg/dL and their HDL-C levels were \< 35 mg/dL. This latter group got a 28% risk reduction when fenofibrate was added to statin therapy as compared to placebo therapy^[@bib20])^.

It has long been known that hypertriglyceridemia is associated with decreased HDL-C values, as well as increased levels of sdLDL-C^[@bib21]--[@bib23])^. This latter parameter can now be readily measured with an automated assay^[@bib24])^. In addition, it has been reported that elevated levels of RLP-C, sdLDL-C, and LDL-TG, and decreased levels of HDL-C and its subfractions have been associated with increased CVD risk^[@bib21]--[@bib33])^. However, these new assays have not been applied to a large diabetic and prediabetic population, especially in an Asian population.

Aim
===

Our purpose in the present study was to evaluate potential differences in the levels of RLP-C, direct LDL-C, large-buoyant LDL-C (lbLDL-C), sdLDL-C, HDL-C, HDL3-C, HDL2-C, and apoE-HDL-C among individuals with type 2 diabetes, prediabetes, or normal glucose tolerance using novel automated assays. Another goal of this investigation was to examine relationships between lipoprotein subfractions and measures of glucose homeostasis, including insulin, and measures of insulin resistance and production in normal, prediabetic, and diabetic subjects in a large Asian population.

Methods
=======

Our study population consisted of 2,049 men and women living in Yi-lan County in northern Taiwan. Residents of this province are native to the island of Taiwan and are not recent immigrants from mainland China or other parts of Asia. All subjects agreed to participate in this study using a standard study protocol and informed consent approved by the research committees of Luodong Poh-ai Hospital, Luodong, Taiwan and the School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan. (M2000-2350).

We recruited normal, prediabetic, and diabetic subjects from participants after testing and participation in a standard health examination as previously described^[@bib34])^. Subjects were classified as normal if their fasting serum glucose value was \< 100 mg/dL, as prediabetic if their value was in the 100--125 mg/dL range, and as diabetic if their value was \> 125 mg/dL using the standard criteria. In order to increase our diabetic subjects, subjects with diabetes were also recruited from a clinic at Luodong Poh-ai Hospital, and were required to have a history of diabetes without any change in treatment including medications for at least 6 months. All diabetic patients received standardized therapies consistent with national Taiwanese, American Diabetes Association and European Association for the Study of Diabetes guidelines. All participants were classified as being obese if their body mass index (BMI) was ≥ 27 kg/m^2^ (Taiwanese criteria), or in some analyses (see **Supplemental Tables**) as ≥ 25 kg/m^2^ (Japanese criteria)^[@bib35]--[@bib37])^.

Subjects being treated for thyroid disease, or those with laboratory evidence of liver disease (transaminase value \> three times the upper limits of normal), or kidney disease (creatinine \> 2.0 mg/dL), or those receiving insulin therapy were excluded from the study. Among the participants, 667 were in the normal group, 345 were in the prediabetic group, and 1,037 were in the diabetic group. In all subjects, a standard history about health status and medication use was obtained, and a physical examination was carried out including measurements of height, weight, and blood pressure. Subjects with a significant history of CVD were excluded from this analysis.

Blood samples were collected from all participants after an overnight fast of 12 hours or more. Serum glucose was measured using the hexokinase method, glycosylated hemoglobin using a turbidimetric inhibition immunoassay as previously described^[@bib34])^. Insulin levels were measured by chemiluminescence assay on a Siemens Centaur automated platform (Siemens Healthineers, Germany) with intra- and inter-assay coefficients of variation (CVs) of \< 5%. Serum creatinine, liver transaminases, TC, TG, HDL-C, HDL3-C, apoE-HDL-C, direct LDL-C, sdLDL-C, LDL-TG, and RLP-C were measured by automated standardized enzymatic analysis on a Cobas C501 analyzer (Roche Diagnostics, Germany). The specialized lipid assay kits were provided by the Denka-Seiken Corporation (Tokyo, Japan) as previously described^[@bib24],\ [@bib31],\ [@bib32],\ [@bib38]--[@bib43])^. All specialized lipid assays had within and between run CVs were \< 6.0%, and in most cases \< 3.0%. Homeostasis model assessment of insulin resistance (HOMA-IR) and homeostasis model assessment of insulin production (HOMA-*β*) were calculated from glucose and insulin levels using the following formulas: HOMA~*β*~ = \[(insulin in µU/mL × 360)/(glucose in mg/dL − 63)\] %), and HOMA~IR~ = \[glucose in mg/dL × (insulin in µU/mL)/405)\]^[@bib44],\ [@bib45])^. lbLDL-C were calculated by subtracting sdLDL-C from direct LDL-C. HDL2-C were calculated by subtracting HDL3-C from HDL-C. LDL-C was calculated using the Friedewald formula by subtracting the sum of HDL-C and TG/5 from TC.

Data are presented as the median values with inter-quartile ranges since many variables were not normally distributed. All statistical analyses were performed using SPSS version 22 (IBM, Armonk, NY). Mann--Whitney *U* testing was used to assess the statistical significance of differences for assessed variables between groups. Pearson\'s correlation coefficients were used for assessing the significance of correlations between variables. A *P* value of \< 0.05 was considered statistically significant.

Results
=======

Data on all male (*n* = 1,030) and female (*n* = 1,019) participants are shown in **[Tables 1](#T1){ref-type="table"}** and **[2](#T2){ref-type="table"}**, respectively. Since this study focused on lipoprotein subfractions, data on male (*n* = 605) and female (*n* = 622) subjects off lipid-lowering medications are shown in **[Table 3](#T3){ref-type="table"}** and **[4](#T4){ref-type="table"}**, respectively, while data on men (*n* = 347) and women (*n* = 339) on statin therapy are shown in **[Tables 5](#T5){ref-type="table"}** and **[6](#T6){ref-type="table"}**, respectively. In addition, we tabulated relative percentage differences between normal, prediabetic, and diabetic male and female subjects for all lipoprotein subfractions in all subjects, those off statins, and in those on statin therapy in **[Figs. 1](#F1){ref-type="fig"}**, **[2](#F2){ref-type="fig"}**, and **[3](#F3){ref-type="fig"}**, respectively. In addition, we have analyzed the effects of obesity classified as ≥ 27 kg/m^2^ using the Taiwanese criteria in normal prediabetic and diabetic subgroups for men in **[Table 7](#T7){ref-type="table"}**, and for women in **[Table 8](#T8){ref-type="table"}**. Comparisons of normal, prediabetic, and diabetic men and women with and without obesity classified as ≥ 25 kg/m^2^ using Japanese criteria are shown in **[Supplemental Tables 1](#T9){ref-type="table"}** and **[2](#T10){ref-type="table"}**. Comparison of variables between participants with and without statin use are shown in **[Supplemental Table 3](#T11){ref-type="table"}--[5](#T13){ref-type="table"}** (normal group in **[Supplemental Table 3](#T11){ref-type="table"}**, prediabetic group in **[Supplemental Table 4](#T12){ref-type="table"}**, and DM group in **[Supplemental Table 5](#T13){ref-type="table"}**). Correlations between variables for all subjects, men and women are shown in **[Supplemental Tables 6](#T14){ref-type="table"}**, **[7](#T15){ref-type="table"}**, and **[8](#T16){ref-type="table"}**.

###### Characteristics of all male subjects (*n* = 1030)[\*](#tf1){ref-type="table-fn"}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                       NGT\                                          PreDM\                                        DM\                                            *P* value           
                                 *n* = 277                                     *n* = 200                                     *n* = 553                                                          
  ------------------------------ --------------------------------------------- --------------------------------------------- ---------------------------------------------- ----------- ------- -------
  Age, year                      55.8 (20.3)                                   60.6 (18.6)                                   61.5 (14.6)                                    0.002       0.098   0.000

  BMI, kg/m^2^                   24.2 (4.2)                                    25.3 (3.9)                                    26.1 (4.8)                                     0.001       0.001   0.000

  Obesity Prevalence             50 (18.1%)[\*\*](#tf2){ref-type="table-fn"}   53 (26.5%)[\*\*](#tf2){ref-type="table-fn"}   217 (39.2%)[\*\*](#tf2){ref-type="table-fn"}   0.001       0.001   0.000

  Systolic BP, mmHg              123.0 (16.8)                                  128.0 (21.0)                                  130.0 (14.0)                                   0.004       0.738   0.002

  Diastolic BP, mmHg             75.0 (13.8)                                   76.0 (16.0)                                   70.0 (10.0)                                    0.022       0.073   0.471

  Fasting Glucose, mg/dL         93.0 (8.0)                                    105.0 (9.0)                                   133.0 (40.0)                                   0.000       0.000   0.000

  HbA1c, %                       5.5 (0.4)                                     5.8 (0.4)                                     6.9 (1.3)                                      0.000       0.000   0.000

  Insulin,                       8.0 (1.5)                                     10.6 (21.2)                                   10.7 (10.4)                                    0.000       0.823   0.000

  HOMA-IR                        1.8 (1.7)                                     2.8 (2.2)                                     3.5 (3.6)                                      0.000       0.000   0.000

  HOMA-*β*                       100.4 (90.4)                                  86.5 (58.7)                                   58.9 (65.8)                                    0.018       0.000   0.000

  Lipids and Lipoproteins                                                                                                                                                                       

      Total cholesterol, mg/dL   192.0 (55.0)                                  189.5 (43.3)                                  171.0 (39.2)                                   0.507       0.000   0.000

      Triglycerides, mg/dL       103.0 (75.0)                                  120.0 (87.0)                                  118.0 (94.0)                                   0.002       0.888   0.000

      RLP-C, mg/dL               6.3 (7.3)                                     8.7 (10.7)                                    6.3 (9.1)                                      0.001       0.001   0.984

      LDL-C, mg/dL               113.3 (46.7)                                  111.8 (43.7)                                  106.4 (32.7)                                   0.880       0.032   0.008

      calculated LDL-C, mg/dL    115.2 (51.1)                                  109.4 (43.8)                                  93.2 (35.7)                                    0.176       0.000   0.000

      sdLDL-C, mg/dL             29.5 (22.2)                                   34.5 (25.0)                                   32.7 (20.4)                                    0.018       0.251   0.052

      sdLDL-C/LDL-C ratio        0.260 (0.111)                                 0.305 (0.150)                                 0.299 (0.153)                                  0.000       0.896   0.000

      lbLDL-C, mg/dL             80.1 (34.1)                                   78.0 (33.8)                                   73.2 (27.0)                                    0.094       0.028   0.000

      LDL-TG, mg/dL              22.2 (11.0)                                   23.3 (10.1)                                   19.4 (7.7)                                     0.006       0.000   0.000

      Non-HDL-C, mg/dL           140.7 (54.8)                                  138.7 (41.6)                                  122.7 (38.1)                                   0.945       0.000   0.000

      HDL-C, mg/dL               51.3 (17.2)                                   50.3 (16.1)                                   46.0 (13.5)                                    0.460       0.000   0.000

      HDL~2~-C, mg/dL            26.9 (13.3)                                   27.0 (10.0)                                   25.1 (8.1)                                     0.447       0.069   0.005

      HDL~3~-C, mg/dL            22.8 (5.1)                                    22.8 (5.2)                                    20.5 (5.2)                                     0.784       0.000   0.000

      ApoE-HDL, mg/dL            4.6 (2.2)                                     4.7 (2.0)                                     3.9 (1.7)                                      0.879       0.000   0.000
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 kg/m^2^).

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

###### Characteristics of all female subjects (*n* = 1019)[\*](#tf3){ref-type="table-fn"}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                       NGT\                                         PreDM\                                        DM\                                            *P* value           
                                 *n* = 390                                    *n* = 145                                     *n* = 484                                                          
  ------------------------------ -------------------------------------------- --------------------------------------------- ---------------------------------------------- ----------- ------- -------
  Age, year                      51.7 (16.4)                                  61.5 (18.8)                                   63.7 (12.3)                                    0.000       0.018   0.000

  BMI, kg/m^2^                   22.8 (4.0)                                   23.8 (4.6)                                    25.5 (5.0)                                     0.001       0.000   0.000

  Obesity Prevalence             36 (9.2%)[\*\*](#tf4){ref-type="table-fn"}   31 (21.4%)[\*\*](#tf4){ref-type="table-fn"}   172 (35.5%)[\*\*](#tf4){ref-type="table-fn"}   0.001       0.000   0.000

  Systolic BP, mmHg              118.0 (19.0)                                 123.0 (16.0)                                  130.0 (14.0)                                   0.003       0.000   0.000

  Diastolic BP, mmHg             69.0 (14.0)                                  71.0 (14.3)                                   70.0 (10.0)                                    0.028       0.076   0.000

  Fasting Glucose, mg/dL         90.0 (9.0)                                   105.0 (11.0)                                  132.0 (41.0)                                   0.000       0.000   0.000

  HbA1c, %                       5.5 (0.4)                                    5.9 (0.5)                                     7.0 (1.4)                                      0.000       0.000   0.000

  Insulin,                       8.3 (5.8)                                    12.7 (8.3)                                    13.2 (10.1)                                    0.000       0.251   0.000

  HOMA-IR                        1.8 (1.3)                                    3.3 (2.4)                                     4.3 (4.0)                                      0.000       0.000   0.000

  HOMA-*β*                       113.1 (76.4)                                 97.7 (67.8)                                   66.1 (68.0)                                    0.004       0.000   0.000

  Lipids and Lipoproteins                                                                                                                                                                      

      Total cholesterol, mg/dL   197.0 (48.8)                                 194.0 (42.0)                                  175.0 (36.3)                                   0.254       0.000   0.000

      Triglycerides, mg/dL       86.5 (58.8)                                  116.0 (94.0)                                  119.0 (82.3)                                   0.000       0.983   0.000

      RLP-C, mg/dL               5.3 (4.7)                                    7.9 (9.8)                                     6.2 (7.6)                                      0.000       0.000   0.000

      LDL-C, mg/dL               117.0 (39.6)                                 114.3 (42.7)                                  106.6 (35.5)                                   0.448       0.007   0.000

      calculated LDL-C, mg/dL    116.7 (42.9)                                 112.3 (42.1)                                  95.1 (34.7)                                    0.098       0.000   0.000

      sdLDL-C, mg/dL             27.3 (17.1)                                  33.5 (21.4)                                   31.5 (19.6)                                    0.000       0.165   0.000

      sdLDL-C/LDL-C ratio        0.231 (0.085)                                0.287 (0.127)                                 0.290 (0.129)                                  0.000       0.813   0.000

      lbLDL-C, mg/dL             87.9 (28.0)                                  80.6 (29.3)                                   74.5 (26.5)                                    0.001       0.002   0.000

      LDL-TG, mg/dL              21.2 (10.0)                                  25.2 (10.5)                                   20.9 (8.3)                                     0.000       0.000   0.857

      Non-HDL-C, mg/dL           134.4 (48.1)                                 139.3 (41.7)                                  121.6 (36.3)                                   0.335       0.000   0.000

      HDL-C, mg/dL               59.2 (18.4)                                  52.2 (17.9)                                   52.5 (15.8)                                    0.000       0.962   0.000

      HDL~2~-C, mg/dL            34.0 (14.7)                                  28.9 (11.8)                                   29.4 (11.0)                                    0.000       0.171   0.000

      HDL~3~-C, mg/dL            25.0 (4.7)                                   23.9 (5.4)                                    22.8 (5.6)                                     0.018       0.001   0.000

      ApoE-HDL, mg/dL            5.7 (2.3)                                    5.0 (2.0)                                     4.7 (1.9)                                      0.000       0.020   0.000
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 kg/m^2^).

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HO MA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell ; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides; non HDL-C, non HDL cholesterol;

###### Characteristics of male subjects not on lipid medications (*n* = 605)[\*](#tf5){ref-type="table-fn"}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                       NGT\                                          PreDM\                                        DM\                                           *P* value           
                                 *n* = 207                                     *n* = 117                                     *n* = 281                                                         
  ------------------------------ --------------------------------------------- --------------------------------------------- --------------------------------------------- ----------- ------- -------
  Age, year                      52.2 (18.3)                                   54.5 (18.5)                                   61.9 (13.4)                                   0.017       0.000   0.000

  BMI, kg/m^2^                   23.9 (4.1)                                    25.3 (4.0)                                    25.4 (4.7)                                    0.000       0.710   0.000

  Obesity Prevalence             36 (17.4%)[\*\*](#tf6){ref-type="table-fn"}   36 (30.8%)[\*\*](#tf6){ref-type="table-fn"}   94 (33.5%)[\*\*](#tf6){ref-type="table-fn"}   0.000       0.710   0.000

  Systolic BP, mmHg              122.0 (15.8)                                  130.0 (22.0)                                  130.0 (14.0)                                  0.001       0.579   0.021

  Diastolic BP, mmHg             74.0 (13.0)                                   77.0 (17.0)                                   76.0 (10.0)                                   0.006       0.280   0.187

  Fasting Glucose, mg/dL         92.0 (7.5)                                    105.0 (10.0)                                  134.0 (35.0)                                  0.000       0.000   0.000

  HbA1c, %                       5.5 (0.4)                                     5.8 (0.5)                                     6.9 (1.1)                                     0.000       0.000   0.000

  Insulin,                       7.9 (7.4)                                     10.6 (8.9)                                    10.5 (10.7)                                   0.000       0.934   0.000

  HOMA-IR                        1.8 (1.6)                                     2.7 (2.3)                                     3.3 (3.7)                                     0.000       0.006   0.000

  HOMA-*β*                       99.5 (96.2)                                   85.1 (63.5)                                   55.2 (61.7)                                   0.008       0.000   0.000

  Lipids and Lipoproteins                                                                                                                                                                      

      Total cholesterol, mg/dL   196.1 (50.5)                                  192.0 (32.0)                                  171.0 (33.0)                                  0.388       0.000   0.000

      Triglycerides, mg/dL       103.0 (79.5)                                  133.0 (99.0)                                  116.0 (91.0)                                  0.006       0.316   0.013

      RLP-C, mg/dL               6.3 (8.2)                                     10.1 (11.6)                                   5.6 (8.0)                                     0.001       0.000   0.061

      LDL-C, mg/dL               116.7 (44.8)                                  115.5 (40.9)                                  107.2 (30.1)                                  0.686       0.003   0.000

      calculated LDL-C, mg/dL    117.7 (47.3)                                  113.5 (39.9)                                  94.1 (31.0)                                   0.103       0.000   0.000

      sdLDL-C, mg/dL             30.7 (22.9)                                   34.9 (26.1)                                   31.8 (18.8)                                   0.075       0.032   0.957

      sdLDL-C/LDL-C ratio        0.256 (0.118)                                 0.310 (0.164)                                 0.288 (0.139)                                 0.004       0.386   0.003

      lbLDL-C, mg/dL             84.9 (33.0)                                   79.7 (32.5)                                   74.6 (25.2)                                   0.115       0.021   0.000

      LDL-TG, mg/dL              22.1 (11.3)                                   23.4 (10.9)                                   18.1 (6.6)                                    0.026       0.000   0.000

      Non HDL-C, mg/dL           142.9 (52.2)                                  141.6 (33.2)                                  122.8 (30.9)                                  0.815       0.000   0.000

      HDL-C, mg/dL               51.6 (18.1)                                   51.4 (18.0)                                   46.0 (13.6)                                   0.551       0.003   0.000

      HDL~2~-C, mg/dL            27.6 (13.0)                                   26.3 (12.4)                                   25.2 (8.3)                                    0.448       0.238   0.015

      HDL~3~-C, mg/dL            23.0 (5.8)                                    22.9 (5.5)                                    20.5 (5.1)                                    0.899       0.000   0.000

      ApoE-HDL, mg/dL            4.6 (2.1)                                     4.8 (2.1)                                     3.7 (1.5)                                     0.857       0.000   0.000
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 kg/m^2^).

Apo , apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

###### Characteristics of female subjects not on lipid medications (*n* = 622)[\*](#tf7){ref-type="table-fn"}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                       NGT\                                         PreDM\                                        DM\                                           *P* value           
                                 *n* = 324                                    *n* = 90                                      *n* = 208                                                         
  ------------------------------ -------------------------------------------- --------------------------------------------- --------------------------------------------- ----------- ------- -------
  Age, year                      49.3 (12.9)                                  54.7 (19.2)                                   63.6 (11.9)                                   0.000       0.000   0.000

  BMI, kg/m^2^                   22.5 (4.0)                                   24.1 (5.2)                                    24.8 (4.8)                                    0.000       0.285   0.000

  Obesity Prevalence             25 (7.7%)[\*\*](#tf8){ref-type="table-fn"}   23 (25.6%)[\*\*](#tf8){ref-type="table-fn"}   57 (27.4%)[\*\*](#tf8){ref-type="table-fn"}   0.000       0.285   0.000

  Systolic BP, mmHg              117.0 (19.0)                                 120.0 (17.0)                                  130.0 (19.5)                                  0.025       0.001   0.000

  Diastolic BP, mmHg             68.0 (14.0)                                  70.5 (11.8)                                   70.0 (10.0)                                   0.086       0.056   0.001

  Fasting Glucose, mg/dL         89.5 (8.0)                                   105.0 (11.0)                                  132.0 (39.5)                                  0.000       0.000   0.000

  HbA1c, %                       5.4 (0.4)                                    5.8 (0.7)                                     7.0 (1.2)                                     0.000       0.000   0.000

  Insulin,                       7.9 (5.6)                                    11.9 (8.2)                                    12.0 (9.4)                                    0.000       0.669   0.000

  HOMA-IR                        1.8 (1.3)                                    3.2 (2.2)                                     4.0 (3.6)                                     0.000       0.002   0.000

  HOMA-*β*                       110.7 (76.0)                                 95.7 (64.5)                                   60.9 (60.0)                                   0.003       0.000   0.000

  Lipids and Lipoproteins                                                                                                                                                                     

      Total cholesterol, mg/dL   198.0 (47.3)                                 194.5 (38.5)                                  178.0 (31.1)                                  0.678       0.000   0.000

      Triglycerides, mg/dL       81.0 (57.5)                                  106.5 (82.8)                                  118.0 (75.0)                                  0.000       0.395   0.000

      RLP-C, mg/dL               4.8 (4.2)                                    7.0 (8.4)                                     5.3 (6.1)                                     0.000       0.001   0.089

      LDL-C, mg/dL               117.7 (39.2)                                 118.1 (39.5)                                  108.4 (29.7)                                  0.934       0.003   0.000

      calculated LDL-C, mg/dL    117.4 (41.1)                                 113.5 (36.2)                                  99.0 (28.1)                                   0.521       0.000   0.000

      sdLDL-C, mg/dL             26.5 (16.8)                                  32.5 (22.5)                                   29.4 (19.9)                                   0.001       0.179   0.010

      sdLDL-C/LDL-C ratio        0.226 (0.081)                                0.272 (0.103)                                 0.272 (0.124)                                 0.000       0.701   0.000

      lbLDL-C, mg/dL             89.8 (27.4)                                  84.4 (22.7)                                   76.4 (24.1)                                   0.115       0.000   0.000

      LDL-TG, mg/dL              20.1 (9.9)                                   23.3 (10.6)                                   19.3 (7.9)                                    0.000       0.000   0.194

      Non HDL-C, mg/dL           133.4 (48.1)                                 139.7 (38.8)                                  124.4 (33.5)                                  0.216       0.000   0.000

      HDL-C, mg/dL               59.9 (18.8)                                  53.6 (16.7)                                   50.3 (17.2)                                   0.000       0.061   0.000

      HDL~2~-C, mg/dL            34.7 (16.1)                                  29.8 (13.7)                                   28.4 (11.8)                                   0.000       0.479   0.000

      HDL~3~-C, mg/dL            25.1 (4.7)                                   23.9 (5.4)                                    22.2 (5.2)                                    0.186       0.000   0.000

      ApoE-HDL, mg/dL            5.7 (2.3)                                    5.2 (2.3)                                     4.4 (2.0)                                     0.001       0.000   0.000
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 kg/m^2^).

Apo , apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

###### Characteristics of male subjects on statins (*n* = 347)[\*](#tf9){ref-type="table-fn"}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                       NGT\                                           PreDM\                                         DM\                                            *P* value           
                                 *n* = 62                                       *n* = 79                                       *n* = 206                                                          
  ------------------------------ ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ----------- ------- -------
  Age, year                      66.0 (16.2)                                    66.0 (12.7)                                    62.4 (15.2)                                    0.911       0.030   0.089

  BMI, kg/m^2^                   24.7 (3.4)                                     25.0 (4.1)                                     26.6 (4.9)                                     0.923       0.000   0.001

  Obesity Prevalence             14 (22.6%)[\*\*](#tf10){ref-type="table-fn"}   16 (20.3%)[\*\*](#tf10){ref-type="table-fn"}   88 (42.7%)[\*\*](#tf10){ref-type="table-fn"}   0.923       0.001   0.001

  Systolic BP, mmHg              130.0 (15.3)                                   127.0 (12.0)                                   130.0 (10.0)                                   0.630       0.797   0.694

  Diastolic BP, mmHg             75.0 (10.8)                                    75.0 (11.0)                                    70.0 (10.0)                                    0.742       0.878   0.447

  Fasting Glucose, mg/dL         94.0 (7.0)                                     106.0 (8.5)                                    132.0 (39.8)                                   0.000       0.000   0.000

  HbA1c, %                       5.6 (0.3)                                      5.9 (0.4)                                      6.8 (1.4)                                      0.000       0.000   0.000

  Insulin,                       8.5 (6.8)                                      11.2 (8.0)                                     10.4 (7.9)                                     0.000       0.369   0.000

  HOMA-IR                        1.9 (1.5)                                      3.0 (2.1)                                      3.5 (3.0)                                      0.000       0.081   0.000

  HOMA-*β*                       104.0 (68.5)                                   90.4 (51.9)                                    60.0 (56.7)                                    0.669       0.000   0.000

  Lipids and Lipoproteins                                                                                                                                                                         

      Total cholesterol, mg/dL   175.5 (57.2)                                   184.0 (56.0)                                   168.0 (50.8)                                   0.437       0.006   0.141

      Triglycerides, mg/dL       100.5 (47.3)                                   111.0 (69.0)                                   118.0 (88.3)                                   0.119       0.478   0.014

      RLP-C, mg/dL               5.7 (5.6)                                      7.4 (8.3)                                      7.3 (9.4)                                      0.066       0.779   0.096

      LDL-C, mg/dL               102.1 (46.0)                                   106.7 (48.8)                                   104.7 (40.9)                                   0.540       0.881   0.451

      calculated LDL-C, mg/dL    100.6 (51.9)                                   102.4 (46.3)                                   92.0 (41.7)                                    0.628       0.002   0.029

      sdLDL-C, mg/dL             27.5 (15.0)                                    33.4 (22.4)                                    33.2 (21.0)                                    0.070       0.847   0.016

      sdLDL-C/LDL-C ratio        0.265 (0.070)                                  0.288 (0.121)                                  0.304 (0.140)                                  0.054       0.486   0.003

      lbLDL-C, mg/dL             76.0 (32.7)                                    73.8 (31.0)                                    72.4 (26.8)                                    0.639       0.557   0.389

      LDL-TG, mg/dL              22.0 (8.2)                                     22.9 (8.8)                                     20.0 (8.1)                                     0.094       0.000   0.116

      Non HDL-C, mg/dL           122.9 (51.7)                                   131.1 (50.3)                                   119.5 (44.6)                                   0.260       0.013   0.404

      HDL-C, mg/dL               49.9 (16.0)                                    49.4 (13.8)                                    46.8 (14.1)                                    0.651       0.187   0.046

      HDL~2~-C, mg/dL            26.4 (12.9)                                    27.1 (7.9)                                     25.4 (8.4)                                     0.648       0.430   0.201

      HDL~3~-C, mg/dL            22.8 (4.2)                                     22.5 (5.3)                                     20.9 (5.3)                                     0.975       0.006   0.009

      ApoE-HDL, mg/dL            4.5 (2.5)                                      4.6 (1.9)                                      4.1 (1.8)                                      0.884       0.011   0.009
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 kg /m^2^).

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

###### Characteristics of female subjects on statins (*n* = 339)[\*](#tf11){ref-type="table-fn"}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                       NGT\                                           PreDM\                                        DM\                                            *P* value           
                                 *n* = 60                                       *n* = 52                                      *n* = 227                                                          
  ------------------------------ ---------------------------------------------- --------------------------------------------- ---------------------------------------------- ----------- ------- -------
  Age, year                      69.5 (13.0)                                    68.0 (12.8)                                   64.3 (13.1)                                    0.972       0.012   0.011

  BMI, kg/m^2^                   24.0 (4.1)                                     23.5 (4.5)                                    26.2 (5.4)                                     0.297       0.000   0.000

  Obesity Prevalence             10 (16.7%)[\*\*](#tf12){ref-type="table-fn"}   8 (15.4%)[\*\*](#tf12){ref-type="table-fn"}   94 (41.4%)[\*\*](#tf12){ref-type="table-fn"}   0.297       0.001   0.001

  Systolic BP, mmHg              129.5 (18.3)                                   130.0 (10.0)                                  130.0 (10.0)                                   0.793       0.840   0.814

  Diastolic BP, mmHg             76.0 (10.5)                                    77.0 (12.0)                                   70.0 (10.0)                                    0.840       0.602   0.452

  Fasting Glucose, mg/dL         92.0 (8.5)                                     104.5 (10.3)                                  131.0 (42.0)                                   0.000       0.000   0.000

  HbA1c, %                       5.6 (0.5)                                      5.9 (0.4)                                     6.9 (1.3)                                      0.001       0.000   0.000

  Insulin,                       10.1 (7.6)                                     13.4 (10.2)                                   13.7 (10.5)                                    0.009       0.738   0.000

  HOMA-IR                        2.3 (1.7)                                      3.4 (2.6)                                     4.6 (3.9)                                      0.000       0.005   0.000

  HOMA-*β*                       128.9 (85.5)                                   116.4 (75.1)                                  69.2 (72.7)                                    0.097       0.000   0.000

  Lipids and Lipoproteins                                                                                                                                                                        

      Total cholesterol, mg/dL   193.8 (56.0)                                   193.5 (54.5)                                  172.0 (41.0)                                   0.433       0.007   0.000

      Triglycerides, mg/dL       107.6 (68.3)                                   131.5 (106.3)                                 120.0 (78.0)                                   0.003       0.038   0.162

      RLP-C, mg/dL               7.4 (5.8)                                      9.5 (14.6)                                    6.8 (8.7)                                      0.012       0.003   0.809

      LDL-C, mg/dL               112.5 (40.6)                                   110.0 (49.0)                                  104.1 (39.6)                                   0.733       0.490   0.142

      calculated LDL-C, mg/dL    111.2 (52.1)                                   102.9 (55.1)                                  90.7 (35.4)                                    0.261       0.015   0.000

      sdLDL-C, mg/dL             30.0 (17.2)                                    35.8 (21.4)                                   32.8 (16.9)                                    0.077       0.181   0.371

      sdLDL-C/LDL-C ratio        0.278 (0.091)                                  0.330 (0.136)                                 0.301 (0.131)                                  0.003       0.255   0.007

      lbLDL-C, mg/dL             81.7 (31.4)                                    72.2 (29.5)                                   71.7 (27.8)                                    0.067       0.926   0.012

      LDL-TG, mg/dL              23.8 (6.1)                                     26.9 (10.1)                                   21.7 (8.6)                                     0.105       0.000   0.015

      Non HDL-C, mg/dL           135.9 (53.9)                                   138.5 (54.9)                                  117.3 (36.8)                                   0.972       0.002   0.001

      HDL-C, mg/dL               58.2 (15.4)                                    51.0 (12.6)                                   54.0 (13.9)                                    0.002       0.044   0.042

      HDL~2~-C, mg/dL            32.1 (11.1)                                    26.1 (9.1)                                    30.3 (10.2)                                    0.002       0.003   0.152

      HDL~3~-C, mg/dL            24.9 (3.9)                                     22.8 (4.9)                                    23.4 (5.3)                                     0.092       0.875   0.025

      ApoE-HDL, mg/dL            5.8 (2.0)                                      4.9 (1.4)                                     5.0 (1.8)                                      0.007       0.606   0.003
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 k g/m^2^).

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

![(A) Percent differences of lipid variables in all male subjects with prediabetes (PreDM; white column) or diabetes (DM; black column) from non-diabetic. (B) Percent differences of lipid variables in all female subjects with prediabetes (PreDM; white column) or diabetes (DM; black column) from non-diabetic. Star sign (\*) indicate *p* \< 0.05](jat-26-890-g001){#F1}

![(A) Percent differences of lipid variables in male subjects without lipid medication with prediabetes (PreDM; white column) or diabetes (DM; black column) from non-diabetic. (B) Percent differences of lipid variables in all female subjects without lipid medication with prediabetes (PreDM; white column) or diabetes (DM; black column) from nondiabetic. Star sign (\*) indicate *p* \< 0.05](jat-26-890-g002){#F2}

![(A) Percent differences of lipid variables in male subjects on statin treatment with prediabetes (PreDM; white column) or diabetes (DM; black column) from non-diabetic. (B) Percent differences of lipid variables in all female subjects on lipid medication with prediabetes (PreDM; white column) or diabetes (DM; black column) from non-diabetic. Star sign (\*) indicate *p* \< 0.05](jat-26-890-g003){#F3}

###### Effects of Obesity Status (Taiwanese Criteria) on Biochemical Variables in Normal, Prediabetic, and Diabetic Men[\*](#tf13){ref-type="table-fn"}

  Variables                      NGT             PreDM           DM                                                                               
  ------------------------------ --------------- --------------- ------- --------------- --------------- ------- ---------------- --------------- -------
  Age, year                      55.7 (20.7)     54.6 (19.4)     0.338   60.9 (17.9)     58.3 (20.7)     0.669   62.9 (14.9)      60.0 (13.8)     0.000
  BMI, kg/m^2^                   23.5 (3.4)      29.0 (2.5)      0.000   24.2 (2.9)      28.7 (3.3)      0.000   24.1 (2.8)       29.3 (3.1)      0.000
  Systolic BP, mmHg              122.0 (16.0)    128.0 (19.8)    0.004   127.0 (19.5)    131.0 (25.5)    0.026   130.0 (10.5)     130.0 (16.0)    0.929
  Diastolic BP, mmHg             74.0 (14.8)     78.0 (13.8)     0.017   75.0 (15.0)     79.5 (15.0)     0.055   70.0 (10.0)      70.0 (10.0)     0.522
  Fasting Glucose, mg/dL         92.0 (8.0)      93.0 (7.5)      0.222   104.0 (8.3)     105.0 (13.0)    0.196   133.0 (38.3)     135.0 (41.0)    0.291
  HbA1c, %                       5.5 (0.4)       5.6 (0.5)       0.140   5.8 (0.4)       5.8 (0.6)       0.289   6.8 (1.2)        7.1 (1.3)       0.008
  Insulin,                       7.0 (5.8)       13.6 (9.0)      0.000   10.0 (5.9)      17.1 (14.8)     0.000   8.8 (7.2)        14.7 (13.1)     0.000
  HOMA-IR                        1.6 (1.4)       3.1 (2.2)       0.000   2.6 (1.7)       4.6 (4.0)       0.000   2.8 (2.5)        4.9 (4.7)       0.000
  HOMA-*β*                       89.0 (70.5)     183.1 (116.2)   0.000   78.9 (49.1)     131.8 (106.6)   0.000   45.1 (47.7)      77.4 (73.9)     0.000
  Lipids and Lipoproteins                                                                                                                         
      Total cholesterol, mg/dL   192.0 (53.5)    198.1 (65.1)    0.262   188.0 (44.3)    196.0 (37.0)    0.107   171.0 (38.3)     171.0 (43.2)    0.652
      Triglycerides, mg/dL       99.0 (62.3)     144.5 (99.5)    0.000   111.5 (78.3)    147.0 (117.0)   0.046   110.0 (78.0)     134.0 (98.0)    0.000
      RLP-C, mg/dL               6.0 (6.8)       10.1 (13.5)     0.405   7.4 (9.2)       11.8 (11.7)     0.132   5.6 (7.6)        8.0 (10.3)      0.000
      LDL-C, mg/dL               111.4 (43.7)    116.8 (59.7)    0.087   108.5 (40.4)    120.5 (46.8)    0.057   106.3 (30.3)     108.8 (35.3)    0.507
      calculated LDL-C, mg/dL    115.9 (50.7)    115.7 (48.0)    0.413   111.0 (44.5)    115.4 (41.1)    0.319   94.1 (31.4)      94.5 (37.8)     0.817
      sdLDL-C, mg/dL             29.0 (20.5)     35.4 (35.0)     0.000   32.0 (20.7)     43.6 (26.3)     0.001   30.6 (18.8)      36.8 (22.6)     0.000
      sdLDL-C/LDL-C ratio        0.256 (0.112)   0.301 (0.154)   0.001   0.289 (0.128)   0.327 (0.170)   0.008   0.2857 (0.137)   0.324 (0.193)   0.000
      lbLDL-C, mg/dL             80.1 (34.1)     78.7 (39.1)     0.947   78.0 (31.6)     79.7 (36.7)     0.720   74.5 (26.2)      73.0 (29.6)     0.050
      LDL-TG, mg/dL              21.8 (10.3)     25.4 (17.6)     0.000   22.4 (9.5)      27.3 (9.8)      0.003   18.8 (7.0)       20.7 (8.5)      0.001
      Non-HDL-C, mg/dL           139.5 (52.8)    145.6 (58.9)    0.032   137.0 (42.5)    151.1 (39.3)    0.085   119.9 (36.7)     126.0 (36.7)    0.020
      HDL-C, mg/dL               51.9 (17.4)     44.8 (16.1)     0.004   49.5 (16.4)     51.0 (15.4)     0.965   48.2 (13.9)      44.1 (11.4)     0.000
      HDL~2~-C, mg/dL            27.9 (13.2)     24.3 (10.8)     0.001   26.7 (9.2)      28.1 (10.8)     0.962   26.4 (9.5)       23.6 (6.9)      0.000
      HDL~3~-C, mg/dL            23.0 (5.5)      22.3 (5.0)      0.312   22.7 (4.9)      22.9 (6.0)      0.985   21.0 (5.1)       19.9 (4.9)      0.002
      ApoE-HDL, mg/dL            4.7 (2.1)       4.2 (2.4)       0.030   4.7 (2.0)       4.7 (2.1)       0.968   4.0 (1.7)        3.6 (1.5)       0.000

Obesity criteria based on Taiwanese criteria of \< or ≥ 27 kg/m^2^, and all data are expressed as median (interquartile range). The prevalence of obesity was 18.5%, 27.5%, and 40.4% in the NGT, prediabetic, and diabetic groups, respectively.

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides; non HDL-C, Non HDL cholesterol.

###### Effects of Obesity Status (Taiwanese Criteria) on Biochemical Variables in Normal, Prediabetic, and Diabetic Women[\*](#tf14){ref-type="table-fn"}

  Variables                      NGT             PreDM           DM                                                                              
  ------------------------------ --------------- --------------- ------- --------------- --------------- ------- --------------- --------------- -------
  Age, year                      51.2 (16.5)     54.9 (23.6)     0.074   60.0 (18.8)     66.2 (18.8)     0.326   64.5 (12.5)     62.0 (14.0)     0.000
  BMI, kg/m^2^                   22.4 (3.6)      28.7 (2.6)      0.000   22.8 (3.2)      28.6 (2.5)      0.000   23.8 (3.3)      29.2 (3.8)      0.000
  Systolic BP, mmHg              117.5 (19.0)    120.0 (17.5)    0.014   122.0 (17.0)    127.5 (19.5)    0.001   130.0 (13.5)    128.0 (10.0)    0.078
  Diastolic BP, mmHg             69.0 (14.0)     77.0 (13.5)     0.003   70.0 (13.0)     75.5 (14.3)     0.049   70.0 (10.0)     70.0 (10.0)     0.907
  Fasting Glucose, mg/dL         90.0 (9.0)      90.5 (8.3)      0.642   105.0 (10.5)    105.0 (12.5)    0.262   131.0 (41.0)    133.0 (40.3)    0.129
  HbA1c, %                       5.4 (0.5)       5.6 (0.4)       0.550   5.9 (0.6)       6.0 (0.6)       0.039   6.9 (1.3)       7.0 (1.3)       0.138
  Insulin,                       8.0 (5.3)       11.3 (6.1)      0.000   11.3 (7.1)      18.4 (10.0)     0.001   10.9 (8.7)      16.8 (11.8)     0.008
  HOMA-IR                        1.8 (1.3)       2.5 (1.2)       0.000   2.9 (2.0)       4.8 (2.8)       0.005   3.6 (3.3)       5.6 (5.3)       0.005
  HOMA-*β*                       110.7 (72.6)    139.9 (97.9)    0.004   88.7 (62.0)     135.2 (82.3)    0.000   55.2 (52.7)     87.6 (69.7)     0.341
  Lipids and Lipoproteins                                                                                                                        
      Total cholesterol, mg/dL   198.0 (49.0)    191.5 (43.8)    0.106   193.0 (41.0)    204.0 (44.4)    0.863   178.0 (38.0)    172.5 (32.6)    0.146
      Triglycerides, mg/dL       84.0 (57.0)     109.6 (55.5)    0.259   117.0 (111.0)   116.0 (62.0)    0.956   116.0 (83.0)    125.5 (84.0)    0.303
      RLP-C, mg/dL               5.1 (4.7)       6.2 (6.1)       0.732   8.6 (11.7)      7.0 (9.0)       0.514   5.7 (6.8)       7.2 (9.0)       0.399
      LDL-C, mg/dL               117.4 (40.0)    113.4 (33.1)    0.768   117.7 (42.4)    113.4 (36.4)    0.694   105.9 (38.2)    108.2 (32.4)    0.402
      calculated LDL-C, mg/dL    117.2 (42.9)    112.5 (40.0)    0.364   110.4 (41.8)    115.6 (37.8)    0.501   96.9 (31.7)     94.1 (31.6)     0.090
      sdLDL-C, mg/dL             27.2 (17.3)     27.5 (12.2)     0.958   34.7 (20.8)     31.7 (22.5)     0.221   30.7 (19.2)     32.3 (19.2)     0.186
      sdLDL-C/LDL-C ratio        0.230 (0.086)   0.245 (0.061)   0.762   0.298 (0.141)   0.269 (0.126)   0.213   0.285 (0.126)   0.295 (0.150)   0.224
      lbLDL-C, mg/dL             88.0 (28.8)     85.9 (22.9)     0.699   82.3 (31.7)     80.6 (23.4)     0.774   74.1 (27.7)     75.2 (26.2)     0.883
      LDL-TG, mg/dL              20.6 (9.4)      25.0 (9.4)      0.008   25.2 (12.1)     25.7 (8.7)      0.749   20.7 (7.7)      21.4 (9.3)      0.121
      Non HDL-C, mg/dL           134.3 (48.5)    131.9 (49.5)    0.678   138.0 (44.4)    145.4 (39.7)    0.733   122.3 (38.5)    120.6 (31.1)    0.310
      HDL-C, mg/dL               59.9 (18.6)     54.4 (17.8)     0.003   53.5 (16.4)     50.7 (15.6)     0.158   52.8 (16.6)     51.3 (12.7)     0.165
      HDL~2~-C, mg/dL            35.1 (15.5)     30.6 (12.7)     0.005   29.6 (12.4)     28.4 (8.9)      0.165   29.9 (12.1)     28.8 (9.3)      0.050
      HDL~3~-C, mg/dL            25.1 (4.5)      24.2 (5.9)      0.036   24.0 (5.6)      23.3 (4.5)      0.345   22.9 (5.6)      22.7 (5.3)      0.896
      ApoE-HDL, mg/dL            5.8 (2.2)       5.1 (2.2)       0.004   5.1 (2.2)       4.7 (2.4)       0.118   4.7 (2.0)       4.7 (1.8)       0.366

Obesity criteria based on Taiwan definitions of \< or ≥ 27 kg/m^2^, and data are expressed as median (interquartile range). The prevalence of obesity was 6.8%, 22.5%, and 36.4% in the NGT, prediabetic, and diabetic groups, respectively.

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides; non HDL-C, Non HDL cholesterol.

###### Effects of Obesity Status (Japanese Criteria) on Biochemical Variables in Normal, Prediabetic, and Diabetic Men[\*](#tf15){ref-type="table-fn"}

  Variables                      NGT             PreDM           DM                                                                              
  ------------------------------ --------------- --------------- ------- --------------- --------------- ------- --------------- --------------- -------
  Age, year                      56.1 (21.0)     54.0 (20.7)     0.334   61.5 (19.3)     59.6 (18.0)     0.457   63.8 (15.9)     60.4 (14.2)     0.000
  BMI, kg/m^2^                   22.6 (2.6)      26.7 (3.1)      0.000   23.2 (2.4)      27.2 (3.1)      0.000   23.1 (2.1)      28.0 (3.7)      0.000
  Systolic BP, mmHg              121.0 (17.0)    124.0 (16.0)    0.009   123.0 (20.0)    130.0 (23.8)    0.000   130.0 (11.0)    130.0 (14.0)    0.836
  Diastolic BP, mmHg             71.0 (15.0)     77.0 (12.0)     0.002   74.0 (14.0)     80.0 (13.8)     0.002   70.0 (10.0)     70.0 (10.0)     0.375
  Fasting Glucose, mg/dL         92.0 (8.0)      93.0 (7.0)      0.046   104.5 (8.0)     105.0 (9.0)     0.496   134.5 (42.8)    133.0 (36.5)    0.934
  HbA1c, %                       5.5 (0.4)       5.5 (0.4)       0.215   5.8 (0.4)       5.8 (0.5)       0.671   6.8 (1.2)       7.0 (1.3)       0.078
  Insulin,                       6.3 (4.9)       11.9 (8.9)      0.000   8.8 (4.3)       13.0 (10.5)     0.000   7.5 (6.0)       13.3 (11.0)     0.000
  HOMA-IR                        1.4 (1.1)       2.6 (2.1)       0.000   2.3 (1.4)       3.5 (3.0)       0.000   2.6 (2.1)       4.4 (4.1)       0.000
  HOMA-*β*                       82.9 (61.0)     150.2 (111.6)   0.000   76.3 (39.0)     110.8 (81.4)    0.000   40.5 (44.5)     69.1 (66.4)     0.000
  Lipids and Lipoproteins                                                                                                                        
      Total cholesterol, mg/dL   193.0 (53.0)    190.5 (58.3)    0.828   189.5 (45.3)    190.0 (41.0)    0.255   171.0 (37.8)    171.0 (42.0)    0.968
      Triglycerides, mg/dL       94.0 (54.5)     125.0 (90.3)    0.000   108.0 (76.0)    142.0 (94.5)    0.004   102.0 (75.8)    128.0 (94.5)    0.000
      RLP-C, mg/dL               5.7 (6.0)       8.3 (11.9)      0.593   7.1 (8.5)       10.1 (10.6)     0.018   5.0 (6.3)       7.9 (10.0)      0.002
      LDL-C, mg/dL               111.4 (43.2)    113.8 (51.5)    0.480   107.3 (42.7)    118.3 (47.4)    0.031   106.8 (32.0)    106.6 (33.4)    0.448
      calculated LDL-C, mg/dL    118.6 (50.1)    109.9 (46.5)    0.691   113.6 (43.4)    111.5 (42.5)    0.526   94.3 (30.6)     94.1 (36.1)     0.910
      sdLDL-C, mg/dL             28.3 (18.8)     33.5 (29.1)     0.001   29.6 (19.8)     39.5 (24.1)     0.000   29.2 (18.7)     35.4 (21.9)     0.000
      sdLDL-C/LDL-C ratio        0.247 (0.104)   0.289 (0.144)   0.000   0.272 (0.136)   0.317 (0.170)   0.003   0.267 (0.111)   0.320 (0.172)   0.000
      lbLDL-C, mg/dL             81.9 (35.5)     77.8 (34.1)     0.170   78.1 (28.6)     79.5 (37.1)     0.631   75.5 (25.4)     72.1 (28.0)     0.028
      LDL-TG, mg/dL              20.8 (10.3)     24.2 (11.4)     0.000   21.8 (8.1)      25.4 (10.1)     0.000   18.3 (7.6)      20.1 (7.8)      0.012
      Non HDL-C, mg/dL           140.9 (53.8)    139.7 (58.9)    0.268   139.0 (42.3)    139.0 (45.8)    0.108   119.5 (33.9)    125.1 (37.4)    0.052
      HDL-C, mg/dL               53.0 (19.1)     47.1 (16.7)     0.000   49.9 (18.0)     50.1 (14.2)     0.320   50.1 (15.0)     44.6 (11.5)     0.000
      HDL~2~-C, mg/dL            29.1 (13.6)     24.4 (9.7)      0.000   26.8 (11.1)     27.1 (9.6)      0.475   27.4 (10.3)     24.0 (7.1)      0.000
      HDL~3~-C, mg/dL            23.3 (5.6)      22.3 (5.4)      0.172   22.8 (5.3)      22.5 (5.4)      0.190   21.1 (4.9)      20.3 (5.1)      0.012
      ApoE-HDL, mg/dL            4.8 (2.3)       4.3 (2.2)       0.001   4.7 (2.2)       4.7 (1.9)       0.515   4.2 (1.8)       3.7 (1.5)       0.000

Obesity criteria based on Japanese criteria of \< or ≥ 25 kg/m^2^, and all data are expressed as median (interquartile range). The prevalence of obesity was 40.0%, 51.3%, and 61.6% in the NGT, prediabetic, and diabetic groups, respectively.

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides; non HDL-C, Non HDL cholesterol.

###### Effects of Obesity Status (Japanese Criteria) on Biochemical Variables in Normal, Prediabetic, and Diabetic Women[\*](#tf16){ref-type="table-fn"}

  Variables                      Normal          PreDM           Diabetic                                                                           
  ------------------------------ --------------- --------------- ---------- --------------- --------------- ------- --------------- --------------- -------
  Age, year                      50.5 (16.7)     53.9 (19.8)     0.009      58.1 (18.2)     66.7 (17.2)     0.077   64.5 (13.2)     62.8 (12.9)     0.014
  BMI, kg/m^2^                   21.8 (2.9)      26.6 (2.2)      0.000      22.3 (2.6)      28.0 (3.8)      0.000   22.9 (2.6)      27.9 (3.9)      0.000
  Systolic BP, mmHg              116.5 (20.0)    121.0 (13.0)    0.002      122.0 (20.0)    125.0 (16.0)    0.004   130.0 (14.0)    130.0 (15.0)    0.076
  Diastolic BP, mmHg             68.0 (14.0)     73.0 (12.5)     0.000      70.0 (12.3)     72.0 (15.5)     0.260   70.0 (10.0)     70.0 (10.0)     0.728
  Fasting Glucose, mg/dL         89.0 (8.0)      92.0 (8.0)      0.022      105.0 (11.3)    105.0 (10.8)    0.356   131.0 (39.5)    133.0 (41.0)    0.040
  HbA1c, %                       5.4 (0.5)       5.6 (0.4)       0.001      5.9 (0.6)       6.0 (0.6)       0.012   6.9 (1.1)       7.0 (1.3)       0.037
  Insulin,                       7.5 (5.5)       10.7 (5.6)      0.000      11.1 (7.4)      14.8 (10.3)     0.002   9.4 (8.1)       15.7 (11.5)     0.000
  HOMA-IR                        1.6 (1.3)       2.3 (1.2)       0.000      2.8 (2.2)       4.0 (2.8)       0.011   3.3 (2.7)       5.3 (4.9)       0.000
  HOMA-*β*                       108.0 (71.9)    138.5 (102.6)   0.000      87.0 (59.5)     122.4 (74.0)    0.000   52.8 (49.3)     81.7 (77.6)     0.111
  Lipids and Lipoproteins                                                                                                                           
      Total cholesterol, mg/dL   198.0 (49.0)    194.0 (47.9)    0.645      192.5 (42.8)    196.5 (45.0)    0.659   177.5 (35.1)    174.0 (38.5)    0.613
      Triglycerides, mg/dL       80.0 (56.0)     108.6 (73.0)    0.000      114.5 (115.8)   126.0 (73.8)    0.295   116.0 (83.0)    122.0 (82.5)    0.133
      RLP-C, mg/dL               4.7 (4.2)       6.8 (6.4)       0.980      7.9 (11.5)      9.0 (9.3)       0.626   5.4 (6.4)       6.8 (8.8)       0.129
      LDL-C, mg/dL               115.0 (40.1)    119.6 (39.4)    0.180      117.6 (41.3)    113.9 (40.8)    0.918   105.1 (39.9)    108.4 (31.7)    0.219
      calculated LDL-C, mg/dL    116.8 (41.4)    114.6 (45.5)    0.899      108.6 (41.3)    115.2 (38.7)    0.381   97.5 (32.0)     94.4 (32.5)     0.335
      sdLDL-C, mg/dL             26.4 (15.0)     31.6 (19.4)     0.008      33.6 (20.5)     34.5 (22.5)     0.952   31.4 (18.8)     31.5 (20.2)     0.092
      sdLDL-C/LDL-C ratio        0.226 (0.080)   0.256 (0.097)   0.003      0.294 (0.132)   0.275 (0.115)   0.913   0.285 (0.116)   0.293 (0.147)   0.122
      lbLDL-C, mg/dL             87.8 (27.9)     87.5 (27.8)     0.824      82.6 (32.1)     80.6 (25.8)     0.920   72.3 (27.7)     75.6 (26.7)     0.673
      LDL-TG, mg/dL              20.1 (8.3)      25.1 (9.1)      0.000      23.4 (11.1)     26.2 (8.8)      0.139   20.4 (7.6)      21.4 (8.6)      0.212
      Non-HDL-C, mg/dL           131.3 (49.3)    137.3 (46.3)    0.241      135.8 (44.5)    145.2 (38.9)    0.217   121.6 (39.5)    122.0 (34.2)    0.988
      HDL-C, mg/dL               60.8 (19.3)     55.6 (14.6)     0.000      53.8 (17.0)     51.1 (12.8)     0.030   53.0 (16.2)     51.8 (13.5)     0.157
      HDL~2~-C, mg/dL            36.0 (16.2)     30.8 (12.1)     0.000      30.4 (12.7)     28.1 (9.2)      0.014   30.1 (12.4)     28.9 (9.7)      0.050
      HDL~3~-C, mg/dL            25.2 (4.6)      24.9 (4.3)      0.037      24.0 (5.4)      23.3 (5.2)      0.493   23.0 (5.7)      22.6 (5.5)      0.957
      ApoE-HDL, mg/dL            5.9 (2.4)       5.3 (1.8)       0.000      5.3 (2.1)       4.8 (1.9)       0.029   4.7 (2.0)       4.7 (1.8)       0.479

Obesity criteria based on Japanese criteria of \< or ≥ 25.0 kg/m^2^, and all data are expressed as median (interquartile range). The prevalence of obesity was 26.4%, 36.2%, and 54.8% in the NGT, prediabetic, and diabetic subjects, respectively.

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides; non HDL-C, Non HDL cholesterol.

###### Comparison of variables between normal participants with or without using statin[\*](#tf17){ref-type="table-fn"}

  Variables                      Male Participants                              *p*                                            Female Participants   *p*                                                                                          
  ------------------------------ ---------------------------------------------- ---------------------------------------------- --------------------- --------------------------------------------- ---------------------------------------------- -------
  Age, year                      52.2 (18.3)                                    66.0 (16.2)                                    0.000                 49.3 (12.9)                                   69.5 (13.0)                                    0.000
  BMI, kg/m^2^                   23.9 (4.1)                                     24.7 (3.4)                                     0.044                 22.5 (4.0)                                    24.0 (4.1)                                     0.001
  Obesity Prevalence             36 (17.4%)[\*\*](#tf18){ref-type="table-fn"}   14 (22.6%)[\*\*](#tf18){ref-type="table-fn"}   0.009                 25 (7.7%)[\*\*](#tf18){ref-type="table-fn"}   10 (16.7%)[\*\*](#tf18){ref-type="table-fn"}   0.003
  Systolic BP, mmHg              122.0 (15.8)                                   130.0 (15.3)                                   0.097                 117.0 (19.0)                                  129.5 (18.3)                                   0.000
  Diastolic BP, mmHg             74.0 (13.0)                                    75.0 (10.8)                                    0.348                 68.0 (14.0)                                   76.0 (10.5)                                    0.020
  Fasting Glucose, mg/dL         92.0 (7.5)                                     94.0 (7.0)                                     0.182                 89.5 (8.0)                                    92.0 (8.5)                                     0.000
  HbA1c, %                       5.5 (0.4)                                      5.6 (0.3)                                      0.584                 5.4 (0.4)                                     5.6 (0.5)                                      0.000
  Insulin,                       7.9 (7.4)                                      8.5 (6.8)                                      0.494                 7.9 (5.6)                                     10.1 (7.6)                                     0.004
  HOMA-IR                        1.8 (1.6)                                      1.9 (1.5)                                      0.578                 1.8 (1.3)                                     2.3 (1.7)                                      0.001
  HOMA-*β*                       99.5 (96.2)                                    104.0 (68.5)                                   0.271                 110.7 (76.0)                                  128.9 (85.5)                                   0.483
  Lipids and Lipoproteins                                                                                                                                                                                                                         
      Total cholesterol, mg/dL   196.1 (50.5)                                   175.5 (57.2)                                   0.056                 198.0 (47.3)                                  193.8 (56.0)                                   0.767
      Triglycerides, mg/dL       103.0 (79.5)                                   100.5 (47.3)                                   0.260                 81.0 (57.5)                                   107.6 (68.3)                                   0.000
      RLP-C, mg/dL               6.3 (8.2)                                      5.7 (5.6)                                      0.309                 4.8 (4.2)                                     7.4 (5.8)                                      0.842
      LDL-C, mg/dL               116.7 (44.8)                                   102.1 (46.0)                                   0.194                 117.7 (39.2)                                  112.5 (40.6)                                   0.285
      calculated LDL-C, mg/dL    119.2 (44.3)                                   100.6 (51.9)                                   0.078                 117.3 (40.7)                                  111.2 (52.1)                                   0.342
      sdLDL-C, mg/dL             30.7 (22.9)                                    27.5 (15.0)                                    0.216                 26.5 (16.8)                                   30.0 (17.2)                                    0.218
      sdLDL-C/LDL-C ratio        0.256 (0.118)                                  0.265 (0.070)                                  0.460                 0.226 (0.081)                                 0.278 (0.091)                                  0.000
      lbLDL-C, mg/dL             84.9 (33.0)                                    76.0 (32.7)                                    0.324                 89.8 (27.4)                                   81.7 (31.4)                                    0.019
      LDL-TG, mg/dL              22.1 (11.3)                                    22.0 (8.2)                                     0.419                 20.1 (9.9)                                    23.8 (6.1)                                     0.001
      Non HDL-C, mg/dL           142.9 (52.2)                                   122.9 (51.7)                                   0.062                 133.4 (48.1)                                  135.9 (53.9)                                   0.696
      HDL-C, mg/dL               51.6 (18.1)                                    49.9 (16.0)                                    0.729                 59.9 (18.8)                                   58.2 (15.4)                                    0.088
      HDL~2~-C, mg/dL            27.6 (13.0)                                    26.4 (12.9)                                    0.961                 34.7 (16.1)                                   32.1 (11.1)                                    0.074
      HDL~3~-C, mg/dL            23.0 (5.8)                                     22.8 (4.2)                                     0.279                 25.1 (4.7)                                    24.9 (3.9)                                     0.534
      ApoE-HDL, mg/dL            4.6 (2.1)                                      4.5 (2.5)                                      0.962                 5.7 (2.3)                                     5.8 (2.0)                                      0.354

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 kg/m^2^).

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

###### Comparison of variables between prediabetic participants with or without using statin[\*](#tf19){ref-type="table-fn"}

  Variables                      Male Participants                              *p*                                            Female Participants   *p*                                                                                          
  ------------------------------ ---------------------------------------------- ---------------------------------------------- --------------------- ---------------------------------------------- --------------------------------------------- -------
  Age, year                      54.5 (18.5)                                    66.0 (12.7)                                    0.000                 54.7 (19.2)                                    68.0 (12.8)                                   0.000
  BMI, kg/m^2^                   25.3 (4.0)                                     25.0 (4.1)                                     0.067                 24.1 (5.2)                                     23.5 (4.5)                                    0.079
  Obesity Prevalence             36 (30.8%)[\*\*](#tf20){ref-type="table-fn"}   16 (20.3%)[\*\*](#tf20){ref-type="table-fn"}   0.888                 23 (25.5%)[\*\*](#tf20){ref-type="table-fn"}   8 (15.4%)[\*\*](#tf20){ref-type="table-fn"}   0.371
  Systolic BP, mmHg              130.0 (22.0)                                   127.0 (12.0)                                   0.309                 120.0 (17.0)                                   130.0 (10.0)                                  0.041
  Diastolic BP, mmHg             77.0 (17.0)                                    75.0 (11.0)                                    0.170                 70.5 (11.8)                                    77.0 (12.0)                                   0.136
  Fasting Glucose, mg/dL         105.0 (10.0)                                   106.0 (8.5)                                    0.563                 105.0 (11.0)                                   104.5 (10.3)                                  0.158
  HbA1c, %                       5.8 (0.5)                                      5.9 (0.4)                                      0.807                 5.8 (0.7)                                      5.9 (0.4)                                     0.544
  Insulin,                       10.6 (8.9)                                     11.2 (8.0)                                     0.319                 11.9 (8.2)                                     13.4 (10.2)                                   0.566
  HOMA-IR                        2.7 (2.3)                                      3.0 (2.1)                                      0.449                 3.2 (2.2)                                      3.4 (2.6)                                     0.899
  HOMA-*β*                       85.1 (63.5)                                    90.4 (51.9)                                    0.254                 95.7 (64.5)                                    116.4 (75.1)                                  0.065
  Lipids and Lipoproteins                                                                                                                                                                                                                         
      Total cholesterol, mg/dL   192.0 (32.0)                                   184.0 (56.0)                                   0.306                 194.5 (38.5)                                   193.5 (54.5)                                  0.234
      Triglycerides, mg/dL       133.0 (99.0)                                   111.0 (69.0)                                   0.119                 106.5 (82.8)                                   131.5 (106.3)                                 0.002
      RLP-C, mg/dL               10.1 (11.6)                                    7.4 (8.3)                                      0.029                 7.0 (8.4)                                      9.5 (14.6)                                    0.012
      LDL-C, mg/dL               115.5 (40.9)                                   106.7 (48.8)                                   0.579                 118.1 (39.5)                                   110.0 (49.0)                                  0.124
      calculated LDL-C, mg/dL    114.1 (38.0)                                   106.9 (47.7)                                   0.912                 113.5 (36.2)                                   106.3 (55.2)                                  0.055
      sdLDL-C, mg/dL             34.9 (26.1)                                    33.4 (22.4)                                    0.369                 32.5 (22.5)                                    35.8 (21.4)                                   0.271
      sdLDL-C/LDL-C ratio        0.310 (0.164)                                  0.288 (0.121)                                  0.356                 0.272 (0.103)                                  0.330 (0.136)                                 0.002
      lbLDL-C, mg/dL             79.7 (32.5)                                    73.8 (31.0)                                    0.902                 84.4 (22.7)                                    72.2 (29.5)                                   0.004
      LDL-TG, mg/dL              23.4 (10.9)                                    22.9 (8.8)                                     0.259                 23.3 (10.6)                                    26.9 (10.1)                                   0.168
      Non HDL-C, mg/dL           141.6 (33.2)                                   131.1 (50.3)                                   0.320                 139.7 (38.8)                                   138.5 (54.9)                                  0.614
      HDL-C, mg/dL               51.4 (18.0)                                    49.4 (13.8)                                    0.846                 53.6 (16.7)                                    51.0 (12.6)                                   0.054
      HDL~2~-C, mg/dL            26.3 (12.4)                                    27.1 (7.9)                                     0.851                 29.8 (13.7)                                    26.1 (9.1)                                    0.059
      HDL~3~-C, mg/dL            22.9 (5.5)                                     22.5 (5.3)                                     0.888                 23.9 (5.4)                                     22.8 (4.9)                                    0.205
      ApoE-HDL, mg/dL            4.8 (2.1)                                      4.6 (1.9)                                      0.919                 5.2 (2.3)                                      4.9 (1.4)                                     0.259

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 kg/m^2^).

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

###### Comparison of variables between diabetic participants with or without using statin[\*](#tf21){ref-type="table-fn"}

  Variables                      Male Participants                              *p*                                            Female Participants   *p*                                                                                           
  ------------------------------ ---------------------------------------------- ---------------------------------------------- --------------------- ---------------------------------------------- ---------------------------------------------- -------
  Age, year                      61.9 (13.4)                                    62.4 (15.2)                                    0.521                 63.6 (11.9)                                    64.3 (13.1)                                    0.286
  BMI, kg/m^2^                   25.4 (4.7)                                     26.6 (4.9)                                     0.007                 24.8 (4.8)                                     26.2 (5.4)                                     0.001
  Obesity Prevalence             94 (33.5%)[\*\*](#tf22){ref-type="table-fn"}   88 (42.7%)[\*\*](#tf22){ref-type="table-fn"}   0.001                 57 (27.4%)[\*\*](#tf22){ref-type="table-fn"}   94 (41.4%)[\*\*](#tf22){ref-type="table-fn"}   0.058
  Systolic BP, mmHg              130.0 (14.0)                                   130.0 (10.0)                                   0.945                 130.0 (19.5)                                   130.0 (10.0)                                   0.352
  Diastolic BP, mmHg             76.0 (10.0)                                    70.0 (10.0)                                    0.419                 70.0 (10.0)                                    70.0 (10.0)                                    0.257
  Fasting Glucose, mg/dL         134.0 (35.0)                                   132.0 (39.8)                                   0.311                 132.0 (39.5)                                   131.0 (42.0)                                   0.618
  HbA1c, %                       6.9 (1.1)                                      6.8 (1.4)                                      0.657                 7.0 (1.2)                                      6.9 (1.3)                                      0.189
  Insulin,                       10.5 (10.7)                                    10.4 (7.9)                                     0.495                 12.0 (9.4)                                     13.7 (10.5)                                    0.644
  HOMA-IR                        3.3 (3.7)                                      3.5 (3.0)                                      0.611                 4.0 (3.6)                                      4.6 (3.9)                                      0.757
  HOMA-*β*                       55.2 (61.7)                                    60.0 (56.7)                                    0.522                 60.9 (60.0)                                    69.2 (72.7)                                    0.155
  Lipids and Lipoproteins                                                                                                                                                                                                                          
      Total cholesterol, mg/dL   171.0 (33.0)                                   168.0 (50.8)                                   0.214                 178.0 (31.1)                                   172.0 (41.0)                                   0.971
      Triglycerides, mg/dL       116.0 (91.0)                                   118.0 (88.3)                                   0.579                 118.0 (75.0)                                   120.0 (78.0)                                   0.126
      RLP-C, mg/dL               5.6 (8.0)                                      7.3 (9.4)                                      0.133                 5.3 (6.1)                                      6.8 (8.7)                                      0.073
      LDL-C, mg/dL               107.2 (30.1)                                   104.7 (40.9)                                   0.087                 108.4 (29.7)                                   104.1 (39.6)                                   0.655
      calculated LDL-C, mg/dL    94.1 (30.9)                                    92.7 (40.5)                                    0.141                 101.0 (27.1)                                   91.3 (34.7)                                    0.099
      sdLDL-C, mg/dL             31.8 (18.8)                                    33.2 (21.0)                                    0.056                 29.4 (19.9)                                    32.8 (16.9)                                    0.039
      sdLDL-C/LDL-C ratio        0.288 (0.139)                                  0.304 (0.140)                                  0.298                 0.272 (0.124)                                  0.301 (0.131)                                  0.011
      lbLDL-C, mg/dL             74.6 (25.2)                                    72.4 (26.8)                                    0.394                 76.4 (24.1)                                    71.7 (27.8)                                    0.304
      LDL-TG, mg/dL              18.1 (6.6)                                     20.0 (8.1)                                     0.003                 19.3 (7.9)                                     21.7 (8.6)                                     0.000
      Non HDL-C, mg/dL           122.8 (30.9)                                   119.5 (44.6)                                   0.257                 124.4 (33.5)                                   117.3 (36.8)                                   0.454
      HDL-C, mg/dL               46.0 (13.6)                                    46.8 (14.1)                                    0.587                 50.3 (17.2)                                    54.0 (13.9)                                    0.034
      HDL~2~-C, mg/dL            25.2 (8.3)                                     25.4 (8.4)                                     0.736                 28.4 (11.8)                                    30.3 (10.2)                                    0.144
      HDL~3~-C, mg/dL            20.5 (5.1)                                     20.9 (5.3)                                     0.409                 22.2 (5.2)                                     23.4 (5.3)                                     0.002
      ApoE-HDL, mg/dL            3.7 (1.5)                                      4.1 (1.8)                                      0.039                 4.4 (2.0)                                      5.0 (1.8)                                      0.000

Data are expressed as median (interquartile range).

Data are expressed as number of obese participant (percentage of obese participants) (BMI ≥ 27 kg/m^2^).

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; NGT, normal glucose tolerance; preDM, pre-diabetes mellitus; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

###### Correlations in all subjects[\*\*\*](#tf23){ref-type="table-fn"}

                      TG                                         RLP-C                                      LDL-C                                      Calculated LDL-C                           sdLDL-C                                    sdLDL-C/LDL-C                              lbLDL-C                                    LDL-TG                                     HDL-C                                      HDL~2~-C                                   HDL~3~-C                                   ApoE-HDL
  ------------------- ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------
  Age                 −0.013                                     −0.01                                      −0.143[\*\*](#tf25){ref-type="table-fn"}   −0.142[\*\*](#tf25){ref-type="table-fn"}   −0.088[\*\*](#tf25){ref-type="table-fn"}   −0.008                                     −0.131[\*\*](#tf25){ref-type="table-fn"}   −0.024                                     −0.105[\*\*](#tf25){ref-type="table-fn"}   −0.052[\*](#tf24){ref-type="table-fn"}     −0.196[\*\*](#tf25){ref-type="table-fn"}   −0.135[\*\*](#tf25){ref-type="table-fn"}
  BMI                 0.205[\*\*](#tf25){ref-type="table-fn"}    0.089[\*\*](#tf25){ref-type="table-fn"}    0.026                                      −0.084[\*\*](#tf25){ref-type="table-fn"}   0.174[\*\*](#tf25){ref-type="table-fn"}    0.23[\*\*](#tf25){ref-type="table-fn"}     −0.087[\*\*](#tf25){ref-type="table-fn"}   0.138[\*\*](#tf25){ref-type="table-fn"}    −0.274[\*\*](#tf25){ref-type="table-fn"}   −0.288[\*\*](#tf25){ref-type="table-fn"}   −0.153[\*\*](#tf25){ref-type="table-fn"}   −0.254[\*\*](#tf25){ref-type="table-fn"}
  Systolic BP         0.152[\*\*](#tf25){ref-type="table-fn"}    0.089[\*\*](#tf25){ref-type="table-fn"}    0.014                                      −0.009                                     0.154[\*\*](#tf25){ref-type="table-fn"}    0.219[\*\*](#tf25){ref-type="table-fn"}    −0.088[\*\*](#tf25){ref-type="table-fn"}   0.165[\*\*](#tf25){ref-type="table-fn"}    −0.153[\*\*](#tf25){ref-type="table-fn"}   −0.174[\*\*](#tf25){ref-type="table-fn"}   −0.043                                     −0.136[\*\*](#tf25){ref-type="table-fn"}
  Diastolic BP        0.118[\*\*](#tf25){ref-type="table-fn"}    0.051                                      0.052                                      0.033                                      0.157[\*\*](#tf25){ref-type="table-fn"}    0.176[\*\*](#tf25){ref-type="table-fn"}    −0.037                                     0.145[\*\*](#tf25){ref-type="table-fn"}    −0.131[\*\*](#tf25){ref-type="table-fn"}   −0.164[\*\*](#tf25){ref-type="table-fn"}   0.001                                      −0.106[\*\*](#tf25){ref-type="table-fn"}
  Fasting Glucose     0.245[\*\*](#tf25){ref-type="table-fn"}    0.097[\*\*](#tf25){ref-type="table-fn"}    −0.055[\*](#tf24){ref-type="table-fn"}     −0.194[\*\*](#tf25){ref-type="table-fn"}   0.154[\*\*](#tf25){ref-type="table-fn"}    0.26[\*\*](#tf25){ref-type="table-fn"}     −0.183[\*\*](#tf25){ref-type="table-fn"}   0.013                                      −0.129[\*\*](#tf25){ref-type="table-fn"}   −0.117[\*\*](#tf25){ref-type="table-fn"}   −0.115[\*\*](#tf25){ref-type="table-fn"}   −0.158[\*\*](#tf25){ref-type="table-fn"}
  HbA1c               0.198[\*\*](#tf25){ref-type="table-fn"}    0.071[\*\*](#tf25){ref-type="table-fn"}    −0.052[\*](#tf24){ref-type="table-fn"}     −0.186[\*\*](#tf25){ref-type="table-fn"}   0.126[\*\*](#tf25){ref-type="table-fn"}    0.21[\*\*](#tf25){ref-type="table-fn"}     −0.16[\*\*](#tf25){ref-type="table-fn"}    −0.007                                     −0.15[\*\*](#tf25){ref-type="table-fn"}    −0.132[\*\*](#tf25){ref-type="table-fn"}   −0.142[\*\*](#tf25){ref-type="table-fn"}   −0.183[\*\*](#tf25){ref-type="table-fn"}
  Insulin             0.228[\*\*](#tf25){ref-type="table-fn"}    0.115[\*\*](#tf25){ref-type="table-fn"}    −0.009                                     −0.07[\*\*](#tf25){ref-type="table-fn"}    0.115[\*\*](#tf25){ref-type="table-fn"}    0.182[\*\*](#tf25){ref-type="table-fn"}    −0.094[\*\*](#tf25){ref-type="table-fn"}   0.134[\*\*](#tf25){ref-type="table-fn"}    −0.178[\*\*](#tf25){ref-type="table-fn"}   −0.167[\*\*](#tf25){ref-type="table-fn"}   −0.146[\*\*](#tf25){ref-type="table-fn"}   −0.168[\*\*](#tf25){ref-type="table-fn"}
  HOMA-IR             0.272[\*\*](#tf25){ref-type="table-fn"}    0.138[\*\*](#tf25){ref-type="table-fn"}    −0.024                                     −0.101[\*\*](#tf25){ref-type="table-fn"}   0.116[\*\*](#tf25){ref-type="table-fn"}    0.196[\*\*](#tf25){ref-type="table-fn"}    −0.114[\*\*](#tf25){ref-type="table-fn"}   0.109[\*\*](#tf25){ref-type="table-fn"}    −0.152[\*\*](#tf25){ref-type="table-fn"}   −0.141[\*\*](#tf25){ref-type="table-fn"}   −0.128[\*\*](#tf25){ref-type="table-fn"}   −0.149[\*\*](#tf25){ref-type="table-fn"}
  HOMA-*β*            0.104[\*\*](#tf25){ref-type="table-fn"}    0.107[\*\*](#tf25){ref-type="table-fn"}    0.036                                      0.024                                      0.063[\*\*](#tf25){ref-type="table-fn"}    0.059[\*\*](#tf25){ref-type="table-fn"}    0.004                                      0.173[\*\*](#tf25){ref-type="table-fn"}    −0.11[\*\*](#tf25){ref-type="table-fn"}    −0.099[\*\*](#tf25){ref-type="table-fn"}   −0.099[\*\*](#tf25){ref-type="table-fn"}   −0.09[\*\*](#tf25){ref-type="table-fn"}
  Total cholesterol   0.189[\*\*](#tf25){ref-type="table-fn"}    0.197[\*\*](#tf25){ref-type="table-fn"}    0.779[\*\*](#tf25){ref-type="table-fn"}    0.907[\*\*](#tf25){ref-type="table-fn"}    0.603[\*\*](#tf25){ref-type="table-fn"}    0.167[\*\*](#tf25){ref-type="table-fn"}    0.626[\*\*](#tf25){ref-type="table-fn"}    0.461[\*\*](#tf25){ref-type="table-fn"}    0.323[\*\*](#tf25){ref-type="table-fn"}    0.214[\*\*](#tf25){ref-type="table-fn"}    0.473[\*\*](#tf25){ref-type="table-fn"}    0.438[\*\*](#tf25){ref-type="table-fn"}
  TG                                                             0.618[\*\*](#tf25){ref-type="table-fn"}    0.023                                      −0.084[\*\*](#tf25){ref-type="table-fn"}   0.513[\*\*](#tf25){ref-type="table-fn"}    0.737[\*\*](#tf25){ref-type="table-fn"}    −0.333[\*\*](#tf25){ref-type="table-fn"}   0.534[\*\*](#tf25){ref-type="table-fn"}    −0.292[\*\*](#tf25){ref-type="table-fn"}   −0.323[\*\*](#tf25){ref-type="table-fn"}   −0.122[\*\*](#tf25){ref-type="table-fn"}   −0.207[\*\*](#tf25){ref-type="table-fn"}
  RLP-C               0.618[\*\*](#tf25){ref-type="table-fn"}                                               0.069[\*\*](#tf25){ref-type="table-fn"}    0.027                                      0.377[\*\*](#tf25){ref-type="table-fn"}    0.481[\*\*](#tf25){ref-type="table-fn"}    −0.173[\*\*](#tf25){ref-type="table-fn"}   0.332[\*\*](#tf25){ref-type="table-fn"}    −0.102[\*\*](#tf25){ref-type="table-fn"}   −0.121[\*\*](#tf25){ref-type="table-fn"}   −0.025                                     −0.035
  LDL-C               0.023                                      0.069[\*\*](#tf25){ref-type="table-fn"}                                               0.779[\*\*](#tf25){ref-type="table-fn"}    0.694[\*\*](#tf25){ref-type="table-fn"}    0.106[\*\*](#tf25){ref-type="table-fn"}    0.86[\*\*](#tf25){ref-type="table-fn"}     0.476[\*\*](#tf25){ref-type="table-fn"}    0.136[\*\*](#tf25){ref-type="table-fn"}    0.064[\*\*](#tf25){ref-type="table-fn"}    0.26[\*\*](#tf25){ref-type="table-fn"}     0.241[\*\*](#tf25){ref-type="table-fn"}
  Calculated LDL-C    −0.084[\*\*](#tf25){ref-type="table-fn"}   0.027                                      0.779[\*\*](#tf25){ref-type="table-fn"}                                               0.447[\*\*](#tf25){ref-type="table-fn"}    −0.065[\*\*](#tf25){ref-type="table-fn"}   0.772[\*\*](#tf25){ref-type="table-fn"}    0.381[\*\*](#tf25){ref-type="table-fn"}    0.111[\*\*](#tf25){ref-type="table-fn"}    0.026                                      0.276[\*\*](#tf25){ref-type="table-fn"}    0.208[\*\*](#tf25){ref-type="table-fn"}
  sdLDL-C             0.513[\*\*](#tf25){ref-type="table-fn"}    0.377[\*\*](#tf25){ref-type="table-fn"}    0.694[\*\*](#tf25){ref-type="table-fn"}    0.447[\*\*](#tf25){ref-type="table-fn"}                                               0.76[\*\*](#tf25){ref-type="table-fn"}     0.23[\*\*](#tf25){ref-type="table-fn"}     0.677[\*\*](#tf25){ref-type="table-fn"}    −0.083[\*\*](#tf25){ref-type="table-fn"}   −0.178[\*\*](#tf25){ref-type="table-fn"}   0.168[\*\*](#tf25){ref-type="table-fn"}    0.05[\*](#tf24){ref-type="table-fn"}
  sdLDL-C/LDL-C       0.737[\*\*](#tf25){ref-type="table-fn"}    0.481[\*\*](#tf25){ref-type="table-fn"}    0.106[\*\*](#tf25){ref-type="table-fn"}    −0.065[\*\*](#tf25){ref-type="table-fn"}   0.76[\*\*](#tf25){ref-type="table-fn"}                                                −0.396[\*\*](#tf25){ref-type="table-fn"}   0.532[\*\*](#tf25){ref-type="table-fn"}    −0.256[\*\*](#tf25){ref-type="table-fn"}   −0.328[\*\*](#tf25){ref-type="table-fn"}   −0.003                                     −0.156[\*\*](#tf25){ref-type="table-fn"}
  lbLDL-C             −0.333[\*\*](#tf25){ref-type="table-fn"}   −0.173[\*\*](#tf25){ref-type="table-fn"}   0.86[\*\*](#tf25){ref-type="table-fn"}     0.772[\*\*](#tf25){ref-type="table-fn"}    0.23[\*\*](#tf25){ref-type="table-fn"}     −0.396[\*\*](#tf25){ref-type="table-fn"}                                              0.164[\*\*](#tf25){ref-type="table-fn"}    0.243[\*\*](#tf25){ref-type="table-fn"}    0.213[\*\*](#tf25){ref-type="table-fn"}    0.232[\*\*](#tf25){ref-type="table-fn"}    0.291[\*\*](#tf25){ref-type="table-fn"}
  LDL-TG              0.534[\*\*](#tf25){ref-type="table-fn"}    0.332[\*\*](#tf25){ref-type="table-fn"}    0.476[\*\*](#tf25){ref-type="table-fn"}    0.381[\*\*](#tf25){ref-type="table-fn"}    0.677[\*\*](#tf25){ref-type="table-fn"}    0.532[\*\*](#tf25){ref-type="table-fn"}    0.164[\*\*](#tf25){ref-type="table-fn"}                                               −0.202[\*\*](#tf25){ref-type="table-fn"}   −0.257[\*\*](#tf25){ref-type="table-fn"}   −0.003                                     −0.08[\*\*](#tf25){ref-type="table-fn"}
  non HDL-C           0.311[\*\*](#tf25){ref-type="table-fn"}    0.247[\*\*](#tf25){ref-type="table-fn"}    0.770[\*\*](#tf25){ref-type="table-fn"}    0.920[\*\*](#tf25){ref-type="table-fn"}    0.668[\*\*](#tf25){ref-type="table-fn"}    0.275[\*\*](#tf25){ref-type="table-fn"}    0.568[\*\*](#tf25){ref-type="table-fn"}    0.564[\*\*](#tf25){ref-type="table-fn"}    −0.044[\*\*](#tf25){ref-type="table-fn"}   −0.144[\*\*](#tf25){ref-type="table-fn"}   0.207[\*\*](#tf25){ref-type="table-fn"}    0.089[\*\*](#tf25){ref-type="table-fn"}
  HDL-C               −0.292[\*\*](#tf25){ref-type="table-fn"}   −0.102[\*\*](#tf25){ref-type="table-fn"}   0.136[\*\*](#tf25){ref-type="table-fn"}    0.111[\*\*](#tf25){ref-type="table-fn"}    −0.083[\*\*](#tf25){ref-type="table-fn"}   −0.256[\*\*](#tf25){ref-type="table-fn"}   0.243[\*\*](#tf25){ref-type="table-fn"}    −0.202[\*\*](#tf25){ref-type="table-fn"}                                              0.961[\*\*](#tf25){ref-type="table-fn"}    0.76[\*\*](#tf25){ref-type="table-fn"}     0.971[\*\*](#tf25){ref-type="table-fn"}
  HDL~2~-C            −0.323[\*\*](#tf25){ref-type="table-fn"}   −0.121[\*\*](#tf25){ref-type="table-fn"}   0.064[\*\*](#tf25){ref-type="table-fn"}    0.026                                      −0.178[\*\*](#tf25){ref-type="table-fn"}   −0.328[\*\*](#tf25){ref-type="table-fn"}   0.213[\*\*](#tf25){ref-type="table-fn"}    −0.257[\*\*](#tf25){ref-type="table-fn"}                                              0.961[\*\*](#tf25){ref-type="table-fn"}    0.551[\*\*](#tf25){ref-type="table-fn"}    0.904[\*\*](#tf25){ref-type="table-fn"}
  HDL~3~-C            −0.122[\*\*](#tf25){ref-type="table-fn"}   −0.025                                     0.26[\*\*](#tf25){ref-type="table-fn"}     0.276[\*\*](#tf25){ref-type="table-fn"}    0.168[\*\*](#tf25){ref-type="table-fn"}    −0.003                                     0.232[\*\*](#tf25){ref-type="table-fn"}    −0.003                                     0.76[\*\*](#tf25){ref-type="table-fn"}     0.551[\*\*](#tf25){ref-type="table-fn"}                                               0.809[\*\*](#tf25){ref-type="table-fn"}
  ApoE-HDL            −0.207[\*\*](#tf25){ref-type="table-fn"}   −0.035                                     0.241[\*\*](#tf25){ref-type="table-fn"}    0.208[\*\*](#tf25){ref-type="table-fn"}    0.05[\*](#tf24){ref-type="table-fn"}       −0.156[\*\*](#tf25){ref-type="table-fn"}   0.291[\*\*](#tf25){ref-type="table-fn"}    −0.08[\*\*](#tf25){ref-type="table-fn"}    0.971[\*\*](#tf25){ref-type="table-fn"}    0.904[\*\*](#tf25){ref-type="table-fn"}    0.809[\*\*](#tf25){ref-type="table-fn"}    

Pearson correlations.

A po, apolipoprotein; BMI, body mass index; BP, blood pressure; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

Significance between 0.05 and 0.01

Significance less than 0.01

###### Correlations in male subjects[\*\*\*](#tf26){ref-type="table-fn"}

                      TG                                         RLP-C                                      LDL-C                                      Calculated LDL-C                           sdLDL-C                                    sdLDL-C/LDL-C                              lbLDL-C                                    LDL-TG                                     HDL-C                                      HDL~2~-C                                   HDL~3~-C                                   ApoE-HDL
  ------------------- ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------
  Age                 −0.159[\*\*](#tf28){ref-type="table-fn"}   −0.063[\*](#tf27){ref-type="table-fn"}     −0.129[\*\*](#tf28){ref-type="table-fn"}   −0.099[\*\*](#tf28){ref-type="table-fn"}   −0.205[\*\*](#tf28){ref-type="table-fn"}   −0.172[\*\*](#tf28){ref-type="table-fn"}   −0.024                                     −0.152[\*\*](#tf28){ref-type="table-fn"}   −0.016                                     0.076[\*](#tf27){ref-type="table-fn"}      −0.206[\*\*](#tf28){ref-type="table-fn"}   −0.068[\*](#tf27){ref-type="table-fn"}
  BMI                 0.225[\*\*](#tf28){ref-type="table-fn"}    0.068[\*](#tf27){ref-type="table-fn"}      0.05                                       −0.055                                     0.221[\*\*](#tf28){ref-type="table-fn"}    0.271[\*\*](#tf28){ref-type="table-fn"}    −0.092[\*\*](#tf28){ref-type="table-fn"}   0.143[\*\*](#tf28){ref-type="table-fn"}    −0.26[\*\*](#tf28){ref-type="table-fn"}    −0.272[\*\*](#tf28){ref-type="table-fn"}   −0.145[\*\*](#tf28){ref-type="table-fn"}   −0.225[\*\*](#tf28){ref-type="table-fn"}
  Systolic BP         0.092[\*](#tf27){ref-type="table-fn"}      0.052                                      0.043                                      0.017                                      0.147[\*\*](#tf28){ref-type="table-fn"}    0.167[\*\*](#tf28){ref-type="table-fn"}    −0.047                                     0.148[\*\*](#tf28){ref-type="table-fn"}    −0.003                                     −0.035                                     0.068                                      0.019
  Diastolic BP        0.089[\*](#tf27){ref-type="table-fn"}      −0.002                                     0.088                                      0.079                                      0.15[\*\*](#tf28){ref-type="table-fn"}     0.128[\*\*](#tf28){ref-type="table-fn"}    0.013                                      0.137[\*\*](#tf28){ref-type="table-fn"}    −0.057                                     −0.104[\*](#tf27){ref-type="table-fn"}     0.069                                      −0.017
  Fasting Glucose     0.199[\*\*](#tf28){ref-type="table-fn"}    0.064[\*](#tf27){ref-type="table-fn"}      −0.074[\*](#tf27){ref-type="table-fn"}     −0.193[\*\*](#tf28){ref-type="table-fn"}   0.109[\*\*](#tf28){ref-type="table-fn"}    0.221[\*\*](#tf28){ref-type="table-fn"}    −0.176[\*\*](#tf28){ref-type="table-fn"}   −0.047                                     −0.108[\*\*](#tf28){ref-type="table-fn"}   −0.082[\*\*](#tf28){ref-type="table-fn"}   −0.128[\*\*](#tf28){ref-type="table-fn"}   −0.145[\*\*](#tf28){ref-type="table-fn"}
  HbA1c               0.114[\*\*](#tf28){ref-type="table-fn"}    0.014                                      −0.035                                     −0.154[\*\*](#tf28){ref-type="table-fn"}   0.074[\*](#tf27){ref-type="table-fn"}      0.13[\*\*](#tf28){ref-type="table-fn"}     −0.1[\*\*](#tf28){ref-type="table-fn"}     −0.091[\*\*](#tf28){ref-type="table-fn"}   −0.099[\*\*](#tf28){ref-type="table-fn"}   −0.064[\*](#tf27){ref-type="table-fn"}     −0.138[\*\*](#tf28){ref-type="table-fn"}   −0.142[\*\*](#tf28){ref-type="table-fn"}
  Insulin             0.195[\*\*](#tf28){ref-type="table-fn"}    0.08[\*](#tf27){ref-type="table-fn"}       0.041                                      −0.059                                     0.142[\*\*](#tf28){ref-type="table-fn"}    0.16[\*\*](#tf28){ref-type="table-fn"}     −0.047                                     0.123[\*\*](#tf28){ref-type="table-fn"}    −0.18[\*\*](#tf28){ref-type="table-fn"}    −0.161[\*\*](#tf28){ref-type="table-fn"}   −0.159[\*\*](#tf28){ref-type="table-fn"}   −0.166[\*\*](#tf28){ref-type="table-fn"}
  HOMA-IR             0.203[\*\*](#tf28){ref-type="table-fn"}    0.081[\*\*](#tf28){ref-type="table-fn"}    0.009                                      −0.099[\*\*](#tf28){ref-type="table-fn"}   0.131[\*\*](#tf28){ref-type="table-fn"}    0.173[\*\*](#tf28){ref-type="table-fn"}    −0.082[\*\*](#tf28){ref-type="table-fn"}   0.08[\*\*](#tf28){ref-type="table-fn"}     −0.176[\*\*](#tf28){ref-type="table-fn"}   −0.151[\*\*](#tf28){ref-type="table-fn"}   −0.169[\*\*](#tf28){ref-type="table-fn"}   −0.175[\*\*](#tf28){ref-type="table-fn"}
  HOMA-*β*            0.104[\*\*](#tf28){ref-type="table-fn"}    0.048                                      0.071[\*](#tf27){ref-type="table-fn"}      0.04                                       0.091[\*\*](#tf28){ref-type="table-fn"}    0.065[\*](#tf27){ref-type="table-fn"}      0.03                                       0.161[\*\*](#tf28){ref-type="table-fn"}    −0.13[\*\*](#tf28){ref-type="table-fn"}    −0.125[\*\*](#tf28){ref-type="table-fn"}   −0.096[\*\*](#tf28){ref-type="table-fn"}   −0.098[\*\*](#tf28){ref-type="table-fn"}
  Total cholesterol   0.192[\*\*](#tf28){ref-type="table-fn"}    0.217[\*\*](#tf28){ref-type="table-fn"}    0.785[\*\*](#tf28){ref-type="table-fn"}    0.905[\*\*](#tf28){ref-type="table-fn"}    0.628[\*\*](#tf28){ref-type="table-fn"}    0.201[\*\*](#tf28){ref-type="table-fn"}    0.595[\*\*](#tf28){ref-type="table-fn"}    0.503[\*\*](#tf28){ref-type="table-fn"}    0.331[\*\*](#tf28){ref-type="table-fn"}    0.204[\*\*](#tf28){ref-type="table-fn"}    0.484[\*\*](#tf28){ref-type="table-fn"}    0.459[\*\*](#tf28){ref-type="table-fn"}
  TG                                                             0.564[\*\*](#tf28){ref-type="table-fn"}    0.015                                      −0.12[\*\*](#tf28){ref-type="table-fn"}    0.548[\*\*](#tf28){ref-type="table-fn"}    0.771[\*\*](#tf28){ref-type="table-fn"}    −0.373[\*\*](#tf28){ref-type="table-fn"}   0.6[\*\*](#tf28){ref-type="table-fn"}      −0.263[\*\*](#tf28){ref-type="table-fn"}   −0.311[\*\*](#tf28){ref-type="table-fn"}   −0.072[\*](#tf27){ref-type="table-fn"}     −0.164[\*\*](#tf28){ref-type="table-fn"}
  RLP-C               0.564[\*\*](#tf28){ref-type="table-fn"}                                               0.113[\*\*](#tf28){ref-type="table-fn"}    0.059                                      0.408[\*\*](#tf28){ref-type="table-fn"}    0.477[\*\*](#tf28){ref-type="table-fn"}    −0.142[\*\*](#tf28){ref-type="table-fn"}   0.377[\*\*](#tf28){ref-type="table-fn"}    −0.067[\*](#tf27){ref-type="table-fn"}     −0.093[\*\*](#tf28){ref-type="table-fn"}   0.012                                      0.01
  LDL-C               0.015                                      0.113[\*\*](#tf28){ref-type="table-fn"}                                               0.78[\*\*](#tf28){ref-type="table-fn"}     0.673[\*\*](#tf28){ref-type="table-fn"}    0.084[\*\*](#tf28){ref-type="table-fn"}    0.848[\*\*](#tf28){ref-type="table-fn"}    0.461[\*\*](#tf28){ref-type="table-fn"}    0.157[\*\*](#tf28){ref-type="table-fn"}    0.084[\*\*](#tf28){ref-type="table-fn"}    0.258[\*\*](#tf28){ref-type="table-fn"}    0.269[\*\*](#tf28){ref-type="table-fn"}
  Calculated LDL-C    −0.12[\*\*](#tf28){ref-type="table-fn"}    0.059                                      0.78[\*\*](#tf28){ref-type="table-fn"}                                                0.438[\*\*](#tf28){ref-type="table-fn"}    −0.077[\*](#tf27){ref-type="table-fn"}     0.767[\*\*](#tf28){ref-type="table-fn"}    0.427[\*\*](#tf28){ref-type="table-fn"}    0.135[\*\*](#tf28){ref-type="table-fn"}    0.043                                      0.285[\*\*](#tf28){ref-type="table-fn"}    0.239[\*\*](#tf28){ref-type="table-fn"}
  sdLDL-C             0.548[\*\*](#tf28){ref-type="table-fn"}    0.408[\*\*](#tf28){ref-type="table-fn"}    0.673[\*\*](#tf28){ref-type="table-fn"}    0.438[\*\*](#tf28){ref-type="table-fn"}                                               0.767[\*\*](#tf28){ref-type="table-fn"}    0.178[\*\*](#tf28){ref-type="table-fn"}    0.681[\*\*](#tf28){ref-type="table-fn"}    −0.021                                     −0.138[\*\*](#tf28){ref-type="table-fn"}   0.234[\*\*](#tf28){ref-type="table-fn"}    0.13[\*\*](#tf28){ref-type="table-fn"}
  sdLDL-C/LDL-C       0.771[\*\*](#tf28){ref-type="table-fn"}    0.477[\*\*](#tf28){ref-type="table-fn"}    0.084[\*\*](#tf28){ref-type="table-fn"}    −0.077[\*](#tf27){ref-type="table-fn"}     0.767[\*\*](#tf28){ref-type="table-fn"}                                               −0.438[\*\*](#tf28){ref-type="table-fn"}   0.545[\*\*](#tf28){ref-type="table-fn"}    −0.181[\*\*](#tf28){ref-type="table-fn"}   −0.28[\*\*](#tf28){ref-type="table-fn"}    0.091[\*\*](#tf28){ref-type="table-fn"}    −0.065[\*](#tf27){ref-type="table-fn"}
  lbLDL-C             −0.373[\*\*](#tf28){ref-type="table-fn"}   −0.142[\*\*](#tf28){ref-type="table-fn"}   0.848[\*\*](#tf28){ref-type="table-fn"}    0.767[\*\*](#tf28){ref-type="table-fn"}    0.178[\*\*](#tf28){ref-type="table-fn"}                                               −0.438[\*\*](#tf28){ref-type="table-fn"}   0.125[\*\*](#tf28){ref-type="table-fn"}    0.224[\*\*](#tf28){ref-type="table-fn"}    0.21[\*\*](#tf28){ref-type="table-fn"}     0.175[\*\*](#tf28){ref-type="table-fn"}    0.265[\*\*](#tf28){ref-type="table-fn"}
  LDL-TG              0.6[\*\*](#tf28){ref-type="table-fn"}      0.377[\*\*](#tf28){ref-type="table-fn"}    0.461[\*\*](#tf28){ref-type="table-fn"}    0.427[\*\*](#tf28){ref-type="table-fn"}    0.681[\*\*](#tf28){ref-type="table-fn"}    0.545[\*\*](#tf28){ref-type="table-fn"}    0.125[\*\*](#tf28){ref-type="table-fn"}                                               −0.167[\*\*](#tf28){ref-type="table-fn"}   −0.233[\*\*](#tf28){ref-type="table-fn"}   0.028                                      −0.031
  non HDL-C           0.296                                      0.253                                      0.777                                      0.917                                      0.672                                      0.276                                      0.551                                      0.592                                      −0.001                                     −0.118                                     0.246                                      0.146
  HDL-C               −0.263[\*\*](#tf28){ref-type="table-fn"}   −0.067[\*](#tf27){ref-type="table-fn"}     0.157[\*\*](#tf28){ref-type="table-fn"}    0.135[\*\*](#tf28){ref-type="table-fn"}    −0.021                                     −0.181[\*\*](#tf28){ref-type="table-fn"}   0.224[\*\*](#tf28){ref-type="table-fn"}    −0.167[\*\*](#tf28){ref-type="table-fn"}                                              0.951[\*\*](#tf28){ref-type="table-fn"}    0.759[\*\*](#tf28){ref-type="table-fn"}    0.968[\*\*](#tf28){ref-type="table-fn"}
  HDL~2~-C            −0.311[\*\*](#tf28){ref-type="table-fn"}   −0.093[\*\*](#tf28){ref-type="table-fn"}   0.084[\*\*](#tf28){ref-type="table-fn"}    0.043                                      −0.138[\*\*](#tf28){ref-type="table-fn"}   −0.28[\*\*](#tf28){ref-type="table-fn"}    0.21[\*\*](#tf28){ref-type="table-fn"}     −0.233[\*\*](#tf28){ref-type="table-fn"}   0.951[\*\*](#tf28){ref-type="table-fn"}                                               0.521[\*\*](#tf28){ref-type="table-fn"}    0.883[\*\*](#tf28){ref-type="table-fn"}
  HDL~3~-C            −0.072[\*](#tf27){ref-type="table-fn"}     0.012                                      0.258[\*\*](#tf28){ref-type="table-fn"}    0.285[\*\*](#tf28){ref-type="table-fn"}    0.234[\*\*](#tf28){ref-type="table-fn"}    0.091[\*\*](#tf28){ref-type="table-fn"}    0.175[\*\*](#tf28){ref-type="table-fn"}    0.028                                      0.759[\*\*](#tf28){ref-type="table-fn"}    0.521[\*\*](#tf28){ref-type="table-fn"}                                               0.813[\*\*](#tf28){ref-type="table-fn"}
  ApoE-HDL            −0.164[\*\*](#tf28){ref-type="table-fn"}   0.01                                       0.269[\*\*](#tf28){ref-type="table-fn"}    0.239[\*\*](#tf28){ref-type="table-fn"}    0.13[\*\*](#tf28){ref-type="table-fn"}     −0.065[\*](#tf27){ref-type="table-fn"}     0.265[\*\*](#tf28){ref-type="table-fn"}    −0.031                                     0.968[\*\*](#tf28){ref-type="table-fn"}    0.883[\*\*](#tf28){ref-type="table-fn"}    0.813[\*\*](#tf28){ref-type="table-fn"}    

Pearson correlations.

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

Significance between 0.05 and 0.01

Significance less than 0.01

###### Correlations in female subjects[\*\*\*](#tf29){ref-type="table-fn"}

                      TG                                         RLP-C                                      LDL-C                                      Calculated LDL-C                           sdLDL-C                                    sdLDL-C/LDL-C                              lbLDL-C                                    LDL-TG                                     HDL-C                                      HDL~2~-C                                   HDL~3~-C                                   ApoE-HDL
  ------------------- ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------------
  Age                 0.138[\*\*](#tf31){ref-type="table-fn"}    0.047                                      −0.156[\*\*](#tf31){ref-type="table-fn"}   −0.184[\*\*](#tf31){ref-type="table-fn"}   0.03                                       0.177[\*\*](#tf31){ref-type="table-fn"}    −0.237[\*\*](#tf31){ref-type="table-fn"}   0.104[\*\*](#tf31){ref-type="table-fn"}    −0.181[\*\*](#tf31){ref-type="table-fn"}   −0.154[\*\*](#tf31){ref-type="table-fn"}   −0.186[\*\*](#tf31){ref-type="table-fn"}   −0.194[\*\*](#tf31){ref-type="table-fn"}
  BMI                 0.176[\*\*](#tf31){ref-type="table-fn"}    0.105[\*\*](#tf31){ref-type="table-fn"}    0.014                                      −0.103[\*\*](#tf31){ref-type="table-fn"}   0.116[\*\*](#tf31){ref-type="table-fn"}    0.165[\*\*](#tf31){ref-type="table-fn"}    −0.062                                     0.148[\*\*](#tf31){ref-type="table-fn"}    −0.236[\*\*](#tf31){ref-type="table-fn"}   −0.254[\*\*](#tf31){ref-type="table-fn"}   −0.108[\*\*](#tf31){ref-type="table-fn"}   −0.224[\*\*](#tf31){ref-type="table-fn"}
  Systolic BP         0.173[\*\*](#tf31){ref-type="table-fn"}    0.114[\*\*](#tf31){ref-type="table-fn"}    −0.001                                     −0.026                                     0.136[\*\*](#tf31){ref-type="table-fn"}    0.236[\*\*](#tf31){ref-type="table-fn"}    −0.093[\*](#tf30){ref-type="table-fn"}     0.176[\*\*](#tf31){ref-type="table-fn"}    −0.197[\*\*](#tf31){ref-type="table-fn"}   −0.209[\*\*](#tf31){ref-type="table-fn"}   −0.083[\*](#tf30){ref-type="table-fn"}     −0.185[\*\*](#tf31){ref-type="table-fn"}
  Diastolic BP        0.107[\*](#tf30){ref-type="table-fn"}      0.087[\*](#tf30){ref-type="table-fn"}      0.034                                      0.001                                      0.131[\*\*](#tf31){ref-type="table-fn"}    0.171[\*\*](#tf31){ref-type="table-fn"}    −0.041                                     0.147[\*\*](#tf31){ref-type="table-fn"}    −0.098[\*](#tf30){ref-type="table-fn"}     −0.125[\*\*](#tf31){ref-type="table-fn"}   0.017                                      −0.082[\*](#tf30){ref-type="table-fn"}
  Fasting Glucose     0.288[\*\*](#tf31){ref-type="table-fn"}    0.13[\*\*](#tf31){ref-type="table-fn"}     −0.034                                     −0.193[\*\*](#tf31){ref-type="table-fn"}   0.195[\*\*](#tf31){ref-type="table-fn"}    0.302[\*\*](#tf31){ref-type="table-fn"}    −0.184[\*\*](#tf31){ref-type="table-fn"}   0.076[\*](#tf30){ref-type="table-fn"}      −0.13[\*\*](#tf31){ref-type="table-fn"}    −0.13[\*\*](#tf31){ref-type="table-fn"}    −0.086[\*\*](#tf31){ref-type="table-fn"}   −0.155[\*\*](#tf31){ref-type="table-fn"}
  HbA1c               0.289[\*\*](#tf31){ref-type="table-fn"}    0.136[\*\*](#tf31){ref-type="table-fn"}    −0.068[\*](#tf30){ref-type="table-fn"}     −0.218[\*\*](#tf31){ref-type="table-fn"}   0.181[\*\*](#tf31){ref-type="table-fn"}    0.306[\*\*](#tf31){ref-type="table-fn"}    −0.221[\*\*](#tf31){ref-type="table-fn"}   0.085[\*\*](#tf31){ref-type="table-fn"}    −0.193[\*\*](#tf31){ref-type="table-fn"}   −0.188[\*\*](#tf31){ref-type="table-fn"}   −0.138[\*\*](#tf31){ref-type="table-fn"}   −0.221[\*\*](#tf31){ref-type="table-fn"}
  Insulin             0.267[\*\*](#tf31){ref-type="table-fn"}    0.153[\*\*](#tf31){ref-type="table-fn"}    −0.05                                      −0.082[\*\*](#tf31){ref-type="table-fn"}   0.1[\*\*](#tf31){ref-type="table-fn"}      0.221[\*\*](#tf31){ref-type="table-fn"}    −0.14[\*\*](#tf31){ref-type="table-fn"}    0.143[\*\*](#tf31){ref-type="table-fn"}    −0.206[\*\*](#tf31){ref-type="table-fn"}   −0.196[\*\*](#tf31){ref-type="table-fn"}   −0.157[\*\*](#tf31){ref-type="table-fn"}   −0.199[\*\*](#tf31){ref-type="table-fn"}
  HOMA-IR             0.341[\*\*](#tf31){ref-type="table-fn"}    0.193[\*\*](#tf31){ref-type="table-fn"}    −0.049                                     −0.105[\*\*](#tf31){ref-type="table-fn"}   0.114[\*\*](#tf31){ref-type="table-fn"}    0.239[\*\*](#tf31){ref-type="table-fn"}    −0.148[\*\*](#tf31){ref-type="table-fn"}   0.13[\*\*](#tf31){ref-type="table-fn"}     −0.163[\*\*](#tf31){ref-type="table-fn"}   −0.158[\*\*](#tf31){ref-type="table-fn"}   −0.12[\*\*](#tf31){ref-type="table-fn"}    −0.16[\*\*](#tf31){ref-type="table-fn"}
  HOMA-*β*            0.119[\*\*](#tf31){ref-type="table-fn"}    0.162[\*\*](#tf31){ref-type="table-fn"}    0.012                                      0.008                                      0.055                                      0.074[\*](#tf30){ref-type="table-fn"}      −0.022                                     0.187[\*\*](#tf31){ref-type="table-fn"}    −0.137[\*\*](#tf31){ref-type="table-fn"}   −0.118[\*\*](#tf31){ref-type="table-fn"}   −0.135[\*\*](#tf31){ref-type="table-fn"}   −0.123[\*\*](#tf31){ref-type="table-fn"}
  Total cholesterol   0.204[\*\*](#tf31){ref-type="table-fn"}    0.184[\*\*](#tf31){ref-type="table-fn"}    0.775[\*\*](#tf31){ref-type="table-fn"}    0.913[\*\*](#tf31){ref-type="table-fn"}    0.598[\*\*](#tf31){ref-type="table-fn"}    0.158[\*\*](#tf31){ref-type="table-fn"}    0.654[\*\*](#tf31){ref-type="table-fn"}    0.411[\*\*](#tf31){ref-type="table-fn"}    0.287[\*\*](#tf31){ref-type="table-fn"}    0.188[\*\*](#tf31){ref-type="table-fn"}    0.441[\*\*](#tf31){ref-type="table-fn"}    0.399[\*\*](#tf31){ref-type="table-fn"}
  TG                                                             0.684[\*\*](#tf31){ref-type="table-fn"}    0.037                                      −0.035                                     0.468[\*\*](#tf31){ref-type="table-fn"}    0.69[\*\*](#tf31){ref-type="table-fn"}     −0.277[\*\*](#tf31){ref-type="table-fn"}   0.471[\*\*](#tf31){ref-type="table-fn"}    −0.308[\*\*](#tf31){ref-type="table-fn"}   −0.326[\*\*](#tf31){ref-type="table-fn"}   −0.153[\*\*](#tf31){ref-type="table-fn"}   −0.23[\*\*](#tf31){ref-type="table-fn"}
  RLP-C               0.684[\*\*](#tf31){ref-type="table-fn"}                                               0.021                                      −0.018                                     0.336[\*\*](#tf31){ref-type="table-fn"}    0.486[\*\*](#tf31){ref-type="table-fn"}    −0.206[\*\*](#tf31){ref-type="table-fn"}   0.285[\*\*](#tf31){ref-type="table-fn"}    −0.129[\*\*](#tf31){ref-type="table-fn"}   −0.141[\*\*](#tf31){ref-type="table-fn"}   −0.054                                     −0.066[\*](#tf30){ref-type="table-fn"}
  LDL-C               0.037                                      0.021                                                                                 0.779[\*\*](#tf31){ref-type="table-fn"}    0.727[\*\*](#tf31){ref-type="table-fn"}    0.144[\*\*](#tf31){ref-type="table-fn"}    0.876[\*\*](#tf31){ref-type="table-fn"}    0.49[\*\*](#tf31){ref-type="table-fn"}     0.108[\*\*](#tf31){ref-type="table-fn"}    0.034                                      0.26[\*\*](#tf31){ref-type="table-fn"}     0.216[\*\*](#tf31){ref-type="table-fn"}
  Calculated LDL-C    −0.035                                     −0.018                                     0.779[\*\*](#tf31){ref-type="table-fn"}                                               0.463[\*\*](#tf31){ref-type="table-fn"}    −0.042                                     0.779[\*\*](#tf31){ref-type="table-fn"}    0.334[\*\*](#tf31){ref-type="table-fn"}    0.072[\*](#tf30){ref-type="table-fn"}      −0.01                                      0.26[\*\*](#tf31){ref-type="table-fn"}     0.171[\*\*](#tf31){ref-type="table-fn"}
  sdLDL-C             0.468[\*\*](#tf31){ref-type="table-fn"}    0.336[\*\*](#tf31){ref-type="table-fn"}    0.727[\*\*](#tf31){ref-type="table-fn"}    0.463[\*\*](#tf31){ref-type="table-fn"}                                               0.753[\*\*](#tf31){ref-type="table-fn"}    0.306[\*\*](#tf31){ref-type="table-fn"}    0.683[\*\*](#tf31){ref-type="table-fn"}    −0.115[\*\*](#tf31){ref-type="table-fn"}   −0.196[\*\*](#tf31){ref-type="table-fn"}   0.133[\*\*](#tf31){ref-type="table-fn"}    0.012
  sdLDL-C/LDL-C       0.69[\*\*](#tf31){ref-type="table-fn"}     0.486[\*\*](#tf31){ref-type="table-fn"}    0.144[\*\*](#tf31){ref-type="table-fn"}    −0.042                                     0.753[\*\*](#tf31){ref-type="table-fn"}                                               −0.328[\*\*](#tf31){ref-type="table-fn"}   0.541[\*\*](#tf31){ref-type="table-fn"}    −0.299[\*\*](#tf31){ref-type="table-fn"}   −0.349[\*\*](#tf31){ref-type="table-fn"}   −0.064[\*](#tf30){ref-type="table-fn"}     −0.203[\*\*](#tf31){ref-type="table-fn"}
  lbLDL-C             −0.277[\*\*](#tf31){ref-type="table-fn"}   −0.206[\*\*](#tf31){ref-type="table-fn"}   0.876[\*\*](#tf31){ref-type="table-fn"}    0.779[\*\*](#tf31){ref-type="table-fn"}    0.306[\*\*](#tf31){ref-type="table-fn"}    −0.328[\*\*](#tf31){ref-type="table-fn"}                                              0.2[\*\*](#tf31){ref-type="table-fn"}      0.231[\*\*](#tf31){ref-type="table-fn"}    0.184[\*\*](#tf31){ref-type="table-fn"}    0.268[\*\*](#tf31){ref-type="table-fn"}    0.29[\*\*](#tf31){ref-type="table-fn"}
  LDL-TG              0.471[\*\*](#tf31){ref-type="table-fn"}    0.285[\*\*](#tf31){ref-type="table-fn"}    0.49[\*\*](#tf31){ref-type="table-fn"}     0.334[\*\*](#tf31){ref-type="table-fn"}    0.683[\*\*](#tf31){ref-type="table-fn"}    0.541[\*\*](#tf31){ref-type="table-fn"}    0.2[\*\*](#tf31){ref-type="table-fn"}                                                 −0.277[\*\*](#tf31){ref-type="table-fn"}   −0.323[\*\*](#tf31){ref-type="table-fn"}   −0.06                                      −0.161[\*\*](#tf31){ref-type="table-fn"}
  non HDL-C           0.331                                      0.242                                      0.784                                      0.924                                      0.667                                      0.280                                      0.591                                      0.535                                      −0.089                                     −0.179                                     0.173                                      0.039
  HDL-C               −0.308[\*\*](#tf31){ref-type="table-fn"}   −0.129[\*\*](#tf31){ref-type="table-fn"}   0.108[\*\*](#tf31){ref-type="table-fn"}    0.072[\*](#tf30){ref-type="table-fn"}      −0.115[\*\*](#tf31){ref-type="table-fn"}   −0.299[\*\*](#tf31){ref-type="table-fn"}   0.231[\*\*](#tf31){ref-type="table-fn"}    −0.277[\*\*](#tf31){ref-type="table-fn"}                                              0.965[\*\*](#tf31){ref-type="table-fn"}    0.737[\*\*](#tf31){ref-type="table-fn"}    0.97[\*\*](#tf31){ref-type="table-fn"}
  HDL~2~-C            −0.326[\*\*](#tf31){ref-type="table-fn"}   −0.141[\*\*](#tf31){ref-type="table-fn"}   0.034                                      −0.01                                      −0.196[\*\*](#tf31){ref-type="table-fn"}   −0.349[\*\*](#tf31){ref-type="table-fn"}   0.184[\*\*](#tf31){ref-type="table-fn"}    −0.323[\*\*](#tf31){ref-type="table-fn"}   0.965[\*\*](#tf31){ref-type="table-fn"}                                               0.532[\*\*](#tf31){ref-type="table-fn"}    0.908[\*\*](#tf31){ref-type="table-fn"}
  HDL~3~-C            −0.153[\*\*](#tf31){ref-type="table-fn"}   −0.054                                     0.26[\*\*](#tf31){ref-type="table-fn"}     0.26[\*\*](#tf31){ref-type="table-fn"}     0.133[\*\*](#tf31){ref-type="table-fn"}    −0.064[\*](#tf30){ref-type="table-fn"}     0.268[\*\*](#tf31){ref-type="table-fn"}    −0.06                                      0.737[\*\*](#tf31){ref-type="table-fn"}    0.532[\*\*](#tf31){ref-type="table-fn"}                                               0.786[\*\*](#tf31){ref-type="table-fn"}
  ApoE-HDL            −0.23[\*\*](#tf31){ref-type="table-fn"}    −0.066[\*](#tf30){ref-type="table-fn"}     0.216[\*\*](#tf31){ref-type="table-fn"}    0.171[\*\*](#tf31){ref-type="table-fn"}    0.012                                      −0.203[\*\*](#tf31){ref-type="table-fn"}   0.29[\*\*](#tf31){ref-type="table-fn"}     −0.161[\*\*](#tf31){ref-type="table-fn"}   0.97[\*\*](#tf31){ref-type="table-fn"}     0.908[\*\*](#tf31){ref-type="table-fn"}    0.786[\*\*](#tf31){ref-type="table-fn"}    

Pearson correlations.

Apo, apolipoprotein; BMI, body mass index; BP, blood pressure; HbA1c, glycated hemoglobin; HOMA-IR, homeostatic model assessment on Insulin Resistance; HOMA-*β*, homeostatic model assessment on beta-cell; HDL-C, HDL cholesterol; lbLDL-C, large buoyant LDL cholesterol; LDL-C, LDL cholesterol; RLP-C, remnant lipoprotein cholesterol; sdLDL-C, small dense LDL cholesterol; TG, triglycerides

Significance between 0.05 and 0.01

Significance less than 0.01

For all subjects and for those not receiving or receiving statin therapy, the median BMI, obesity prevalence, systolic blood pressure, serum glucose, HbA1c, serum insulin, and calculated insulin resistance (HOMA~IR~) were all significantly higher in prediabetic and diabetic subjects than in normal subjects. In contrast, median calculated insulin production (HOMA~*β*~) values were significantly lower in prediabetic and diabetic subjects than in normal, especially in those with diabetes (see **[Tables 1](#T1){ref-type="table"}--[6](#T6){ref-type="table"}**). Interestingly serum insulin levels were not significantly different between prediabetic and diabetic subjects in all categories, but there were significantly higher HOMA~IR~ values and significantly lower HOMA~*β*~ values in diabetic subjects than in normal subjects.

In all male prediabetic subjects, TG, RLP-C, sdLDL-C, sdLDL-C/LDL-C ratio, and LDL-TG values were all significantly higher than in normal subjects (see **[Table 1](#T1){ref-type="table"}**). In male prediabetics not on statin therapy, TG, sdLDL-C/LDL-C ratio, and LDL-TG values were all significantly higher than in normal subjects (see **[Table 3](#T3){ref-type="table"}**). In male prediabetics on statin therapy, all these significant differences were abolished (see **[Table 5](#T5){ref-type="table"}**). In all female prediabetic subjects, TG, RLP-C, sdLDL-C, sdLDL-C/LDL-C ratio, and LDL-TG values were all significantly higher than in normal subjects, while lbLDL-C, HDL-C, HDL2-C, and apoE-HDL-C were all significantly lower than in normals (see **[Table 2](#T2){ref-type="table"}**). In female prediabetic subjects off statin therapy, TG, RLP-C, sdLDL-C, sdLDL-C/LDL-C ratio, and LDL-TG values were all significantly higher than in normals, while HDL-C, HDL2-C, and apoE-HDL-C were all significantly lower than in normal subjects (see **[Table 4](#T4){ref-type="table"}**). In female prediabetic subjects on statin therapy, TG, RLP-C, and sdLDL-C/LDL-C ratio values were all significantly higher than in normal, while HDL-C, HDL2-C, and apoE-HDL-C were all significantly lower than in normal (see **[Table 6](#T6){ref-type="table"}**).

In all male diabetic subjects, TG, sdLDL-C/LDL-C ratio, and LDL-TG values were all significantly higher than in normal subjects, while direct LDL-C, calculated LDL-C, non-HDL-C, HDL-C, HDL2-C, HDL3-C, and apoE-HDL-C were all significantly lower than in normal subjects (see **[Table 1](#T1){ref-type="table"}**). In diabetic men not on statin therapy, with very similar differences being observed in diabetic men not on statin therapy versus normal subjects (see **[Table 5](#T5){ref-type="table"}**). In all female diabetics, TG, RLP-C, sdLDL-C, and sdLDL-C/LDL-C ratio values were all significantly higher than in nortmal subjects, while lbLDL-C, HDL-C, and apoE-HDL-C were all significantly lower than in normal subjects. In all female diabetics off statin therapy, TG, sdLDL-C, and sdLDL-C/LDL-C ratio values were all significantly higher than in normal subjects, while direct LDL-C, calculated LDL-C, lbLDL-C, non-HDL-C, HDL-C, HDL2-C, HDL3-C, and apoE-HDL-C were all significantly lower than in normal subjects. Interestingly, median direct LDL-C values in male and female diabetic subjects in all three categories ranged from 104.1--108.4 mg/dL, whereas for calculated LDL-C, these values ranged from 90.7--99.0 mg/dl, with an average underestimation of 11.5% (*p* \< 0.001).

For all groups, we have tabulated relative percent differences between normal, prediabetic, and diabetic male and female subjects for all lipid and lipoprotein subfractions (see **[Figs. 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}**, and **[3](#F3){ref-type="fig"}**). A number of different patterns emerged. One pattern is that prediabetic subjects had the greatest increases in RLP-C, sdLDL-C, and LDL-TG values, especially in female subjects, as compared with normal subjects. Another pattern that emerged is that diabetic subjects had the greatest decreases in HDL-C and its subfractions as compared with normal, especially in men. In women, significant decreases in HDL-C and its subfractions were observed in prediabetic subjects as compared with normal; however, this was not the case for prediabetic men. A final pattern that emerged was that calculated LDL-C significantly underestimated direct LDL-C values in diabetic male and female subjects, with less discrepancy observed in normal and prediabetic subjects.

We examined the effects of obesity classified as having a BMI \> 27 kg/m^2^ versus being non-obese in normal, prediabetic, and diabetic men and women. The data are shown in **[Tables 7](#T7){ref-type="table"}** and **[8](#T8){ref-type="table"}**. In normal men, being obese resulted in significantly higher systolic blood pressure, insulin, HOMA~IR~, HOMA~*β*~, TG, sdLDL-C, sdLDL-C/LDL-C ratio, non-HDL-C, and LDL-TG values, and significantly lower HDL-C, HDL2-C, and apoE-HDL-C as compared with non-obese normal subjects (see **[Table 7](#T7){ref-type="table"}**). In normal women, being obese resulted in the same differences except that TG and non-HDL-C levels were not significantly higher, but HDL3-C was significantly lower as compared with normal subjects (see **[Table 8](#T8){ref-type="table"}**). In prediabetic men, being obese resulted in the same findings as for normal men, except that no significant differences with regard to HDL-C and its subfractions were noted as compared with non-obese prediabetic men. In prediabetic women, being obese resulted in only significantly higher systolic blood pressure, HbA1c, insulin, HOMA~IR~, HOMA~*β*~, but no other parameters, as compared with prediabetic, non-obese women (see **[Table 8](#T8){ref-type="table"}**). In diabetic men, being obese resulted in significantly higher insulin, HOMA~IR~, HOMA~*β*~, TG, RLP-C, sdLDL-C, sdLDL-C/LDL-C ratio, LDL-TG, lbLDL-C, non-HDL-C, and significantly lower levels of HDL-C, HDL2-C, HDL3-C, and apoE-HDL-C, compared with non-obese diabetic men (see **[Table 7](#T7){ref-type="table"}**). In contrast, in diabetic women, being obese was only associated with significantly higher levels of insulin and HOMA~*β*~, and significantly lower levels of HDL2-C, as compared with non-obese diabetic women (see **[Table 8](#T8){ref-type="table"}**). Surprisingly, in this analysis, the presence of obesity had little effect on fasting glucose levels, possibly because group selections by gender were based on this parameter. Similar effects of obesity using the ≥ 25 kg/m^2^ criteria were observed in all of the above subgroups (see **[Supplementary Tables 1](#T9){ref-type="table"}** and **[2](#T10){ref-type="table"}**). It should also be noted that, as previously mentioned, the prevalence of obesity was significantly higher in prediabetic and diabetic men and women versus controls as shown in **[Tables 1](#T1){ref-type="table"}** and **[2](#T2){ref-type="table"}**.

We also examined the effects of statin use in normal men and women (see **[Supplementary Table 3](#T11){ref-type="table"}**), in prediabetic men and women (see **[Supplemental Table 4](#T12){ref-type="table"}**), and in diabetic men and women (see **[Supplementary Table 5](#T13){ref-type="table"}**). In normal men, statin use was significantly associated with being older, having a higher BMI, and having a higher prevalence of obesity as compared with non-users. In prediabetic men, statin use was significantly associated with being older and having lower RLP-C values than non-users. In diabetic men, statin use was significantly associated with higher BMI, obesity prevalence, LDL-TG, and apoE-HDL-C values as compared with non-users. In normal women, statin use was associated with significantly higher age, BMI, obesity prevalence, systolic blood pressure, diastolic blood pressure, glucose, HbA1c, insulin, HOMA~IR~, TG, lbLDL-C, and sdLDL/LDL-C ratio as compared with non-users. In prediabetic women, statin use was significantly associated with higher age, systolic blood pressure, TG, RLP-C, sdLDL/LDL-C ratio, and LDL-TG as compared with non-users. In diabetic women, statin use was significantly associated with higher BMI, sdLDL/LDL-C ratio, LDL-TG, HDL-C, HDL3-C, and apoE-HDL-C as compared with non-users.

We have also examined correlations between parameters in men and women participating in this study (see **[Supplementary Tables 6](#T14){ref-type="table"}**, **[7](#T15){ref-type="table"}**, and **[8](#T16){ref-type="table"}**). We observed very strong correlations between TC, calculated LDL-C, direct LDL-C, sdLDL-C, and LDL-TG, and somewhat weaker correlations between TC and HDL3-C, HDL-C, apoE HDL-C, and RLP-C. The strongest positive correlations with TG levels were with RLP-C, LDL-TG, and sdLDL-C, as well as strong inverse correlation with HDL-C and somewhat weaker correlations with HDL3-C and apoE HDL-C. We also noted that insulin and HOMA~IR~ values were significantly correlated with TG values, while HOMA~B~ was modestly correlated with LDL-TG.

Discussion
==========

In order to prevent CVD in prediabetic and diabetic subjects, not only glycemic control, but control of blood pressure and lipids and their subfractions are also important. Our focus in this study was to carefully examine lipids and lipoprotein subfractions using standard and novel markers in subjects with prediabetes and diabetes as compared with normal subjects in a large Asian population of over 2,000 individuals. In addition, we examined these parameters in both men and women, as well as in those who are off and on lipid-lowering medication. In addition, we related these parameters to markers of glucose homeostasis, namely fasting values of glucose, insulin, HbA1c, and calculated HOMA~IR~ and HOMA~*β*~. Our data reinforces the concept that both increased insulin resistance and decreased insulin production underlie the pathogenesis of prediabetes and the transition to diabetes, and that obesity plays an important role in this process. Recent studies using novel automated assays indicate that elevated levels of sdLDL-C and LDL-TG provide significant information about CVD risk above and beyond standard risk factors, and this may be the case for decreased levels of HDL subfractions and apoE HDL-C as well^[@bib27]--[@bib33],\ [@bib46])^. However, to our knowledge, such new assays have not been applied to a relatively large population of male and female prediabetic and diabetic subjects.

It has long been known that diabetics have dyslipidemia with elevated TG, RLP-C, sdLDL-C, and decreased HDL-C values as compared to controls^[@bib1]--[@bib4])^. However, these older observations were made with a more manual cumbersome method of measuring RLP-C and gradient gel technology for assessing LDL particle size. In addition, more recently, it has been documented that diabetic subjects on statin therapy get additional benefit from the addition of fenofibrate if they have fasting TG values \> 204 mg/dL and HDL-C values \< 35 mg/dL^[@bib17],\ [@bib19])^. It is also known that statins can have beneficial effects not only on calculated LDL-C, but also on TG, RLP-C, direct LDL-C, sdLDL-C, and sdLDL-C^[@bib39])^. While statins clearly have strikingly beneficial effects on CVD risk reduction in prediabetics and diabetics, there is substantial residual risk seen in these subjects on statin treatment^[@bib19])^.

In the present study, fasting triglycerides were significantly higher in male and female prediabetic and diabetic subjects as compared with controls in all subjects, as well as in those on and off lipid-lowering medications, except for male prediabetics and female diabetics on lipid-lowering therapy. RLP-C levels were highest in prediabetics, and in this group, lipid-lowering treatment abolished these differences in men, but not in women. It is known that RLP-C may be an especially important CVD risk factor in women, and it is possible that the addition of fibrates or omega-3 fatty acids on top of statin therapy may be very important to minimize CVD risk^[@bib46])^. With regard to direct LDL-C, calculated LDL-C, and lbLDL-C differences between prediabetes and diabetics versus control subjects were relatively small. An important novel finding in this study was that calculated LDL-C, using the Friedewald formula, significantly underestimated direct LDL-C with the assay used by slightly more than 10%. We therefore recommend the use of direct LDL-C in this population because it is the primary target of lipid-lowering therapy.

It should also be noted that sdLDL has been shown to be the more atherogenic component of LDL. Prediabetic subjects were most likely to have increases in this parameter, as compared with control subjects. However, sdLDL-C differences were greater in female prediabetic and diabetic subjects than in men, and the use of statin therapy in these subjects did not abolish differences in women. These finding indicate that possibly, either more intensive statin therapy or additional treatments such as fibrates or omega-3 fatty acids may be necessary to treat elevated TG-rich lipoproteins and sdLDL-C in prediabetic and diabetic subjects to minimize residual CVD risk^[@bib47])^.

LDL-TG, a new CVD marker, was highest in the prediabetic subjects, and statin therapy did not minimize these differences. Since a recent study has shown that LDL-TG levels are higher in CHD than in controls, our findings may be one of the reasons why prediabetes is linked to atherosclerosis^[@bib32])^. However, it was unexpected that LDL-TG levels were lower in this population in diabetic subjects than in normal subjects. We have observed a modest positive correlation between HOMA~*β*~ and LDL-TG, and since diabetics have lower HOMA~*β*~ values, this may account for this difference. Whether this finding is also true in other populations remains to be confirmed. It should be noted that insulin deficiency and decreased HOMA~*β*~ appears to be more common among Asian diabetics than that observed in western Caucasian populations where obesity and insulin resistance may be more common^[@bib47],\ [@bib48])^. This may also explain why we see differences in LDL-TG values in this population between prediabetic and diabetic subjects.

In addition, direct LDL-C levels were also lower in diabetic subjects, however, sdLDL-C levels were higher or similar to controls, resulting in sdLDL-C/LDL-C ratios in patients with T2DM that were significantly higher than in any other group. A previous study in a Japanese population has assessed cholesterol and TG in twenty lipoprotein subfractions, and documented that smaller LDL particles carry less TG than larger LDL and VLDL particles^[@bib49])^. From this viewpoint, it makes sense that LDL-TG levels are lower in diabetics than in controls, since the number of sdLDL particles increases in patients with diabetes. Our overall data indicate that attempts to normalize sdLDL-C and LDL-TG levels in prediabetic and diabetic subjects need to be made to normalize their CVD risk.

Diabetics in our population and female prediabetics had significantly lower levels of HDL-C and HDL subfractions than controls, placing them at increased CVD risk. We have observed significant correlations between HDL-C, HDL~3~-C, HDL~2~-C, and apoE-HDL-C, and noted significantly lower values in diabetic men and prediabetic and diabetic women as compared to controls. These differences persisted for all parameters in patients on lipid-lowering treatment, except for HDL~2~-C. It is still uncertain whether apoE-rich HDL particles are athero-protective. Similarly, there is an ongoing debate as to whether serum HDL~3~-C is cardioprotective. While serum glucose levels in prediabetes are not high enough to be diagnosed as diabetes, overall, their lipid values are similar to those in diabetics. Our findings on the pattern of lipid profiles support the concept that CVD risk in prediabetics may be as high as in those with diabetes.

The strength of this study is the relatively large number of participants in the 3 groups for both genders. Moreover, we examined subjects on and off statin therapy. The data trends were very similar in all groups. In addition, all subjects were on stable therapy for their lipid alterations as well as for diabetes if present for at least 6 months prior to the study. While absolute values of lipid parameters are known to be influenced by lipid medications, the trends and differences observed when normal, prediabetics, and diabetics were compared, was not greatly different. The participants with diabetes were also taking anti-diabetes medications, mostly metformin, but all subjects receiving insulin were excluded. Metformin and other glucose-lowering medication may affect lipid profiles, but do not cause rapid changes since their diabetic conditions were stable and their medications were not changed for at least 6 months. While we only studied a Taiwanese population, another limitation of this study, these findings need to be replicated in other populations using these newer lipoprotein assays. It should be noted that our study was cross-sectional, and prospective treatment studies in diabetics or prediabetics need to be performed on order to further assess potential changes in the various lipoprotein fractions measured.

Conclusion
==========

In summary, we compared novel lipoprotein parameters in normal, prediabetic and diabetic subjects. Prediabetic subjects were more likely to have elevated TG, RLP-C, sdLDL-C, and LDL-TG, while diabetic subjects were more likely to have decreases in HDL-C and HDL subfractions than normal subjects. These findings indicate that in this large Asian population, prediabetes is associated with greater increases in atherogenic lipoproteins, while diabetes is more likely to be associated with low levels of HDL and its subfractions. These findings suggest that insulin resistance, as seen in prediabetics, plays an important role in modulating changes TG-rich lipoproteins, while both insulin resistance and impaired insulin production, as seen in the diabetic state, may be more important in the regulation of HDL and its subfractions. In our view, both increases in atherogenic lipoproteins and decreases in HDL and its subfractions modulates CVD risk. Weight loss may be the best strategy to improve these abnormalities, and in the case of atherogenic lipoproteins, the combination of statins, fibrates, and omega-3 fatty acids. Moreover, our data indicate that calculated LDL-C significantly underestimated direct LDL-C in subjects with diabetes. In our view, direct LDL-C and sdLDL-C should be measured and optimized in both diabetic and prediabetic subjects to reduce CVD risk.
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